0001104659-21-010906.txt : 20210202 0001104659-21-010906.hdr.sgml : 20210202 20210202160619 ACCESSION NUMBER: 0001104659-21-010906 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 51 CONFORMED PERIOD OF REPORT: 20201231 FILED AS OF DATE: 20210202 DATE AS OF CHANGE: 20210202 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Lifesci Acquisition II Corp. CENTRAL INDEX KEY: 0001819113 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 844278203 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-39727 FILM NUMBER: 21581446 BUSINESS ADDRESS: STREET 1: 250 W 55TH ST. STREET 2: #3401 CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 6468891200 MAIL ADDRESS: STREET 1: 250 W 55TH ST. STREET 2: #3401 CITY: NEW YORK STATE: NY ZIP: 10019 10-Q 1 tm214486d1_10q.htm FORM 10-Q

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended December 31, 2020

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from                  to

 

Commission File No. 001-39727

 

LIFESCI ACQUISITION II CORP.
(Exact name of registrant as specified in its charter)

 

     
Delaware   84-4278203
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification No.)

 

 

250 W. 55th St., #3401

New York, NY 10019

(Address of Principal Executive Offices, including zip code)

 

 
(646) 899-1200
(Registrant’s telephone number, including area code)

 

 
N/A
(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which
registered
Shares of Common Stock, $0.0001 par value   LSAQ   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x  No ¨

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

¨   Large accelerated filer ¨   Accelerated filer
x  Non-accelerated filer x  Smaller reporting company
  x  Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act): Yes x No ¨

 

As of January 29, 2021, there were 10,011,301 shares of common stock, par value $0.0001 per share, issued and outstanding.

 

 

 

 

 

LIFESCI ACQUISITION II CORP.

 

Quarterly Report on Form 10-Q

 

TABLE OF CONTENTS

 

        
      Page 
PART 1 – FINANCIAL INFORMATION  1 
         
Item 1.  Condensed Financial Statements   1 
         
   Condensed Balance Sheets as of December 31, 2020 (unaudited) and June 30, 2020   1 
         
   Condensed Statements of Operations for the Three and Six Months Ended December 31, 2020 (unaudited) and for the Period from December 18, 2019 (inception) Through December 31, 2019 (unaudited)   2 
         
   Condensed Statements of Changes in Stockholders’ Equity for the Three and Six Months Ended December 31, 2020 (unaudited) and for the Period from December 18, 2019 (inception) Through December 31, 2019 (unaudited)   3 
         
   Condensed Statements of Cash Flows for the Six Months Ended December 31, 2020 (unaudited) and for the Period from December 18, 2019 (inception) Through December 31, 2019 (unaudited)   4 
         
   Notes to Condensed Financial Statements (unaudited)   5 
         
Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations   13 
         
Item 3.  Quantitative and Qualitative Disclosures about Market Risk   15 
         
Item 4.  Control and Procedures   15 
         
PART II – OTHER INFORMATION  15 
         
Item 1.  Legal Proceedings   15 
         
Item 1A.  Risk Factors   15 
         
Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds   15 
         
Item 3.  Defaults Upon Senior Securities   16 
         
Item 4.  Mine Safety Disclosures   16 
         
Item 5.  Other Information   16 
         
Item 6.  Exhibits   16 
         
SIGNATURES      18 

 

i

 

 

 

PART 1 – FINANCIAL INFORMATION

 

ITEM 1. CONDENSED FINANCIAL STATEMENTS

 

LIFESCI ACQUISITION II CORP.

CONDENSED BALANCE SHEETS

 

   December 31,   June 30, 
   2020   2020 
   (unaudited)     
ASSETS        
Current assets          
Cash  $783,713   $25,000 
Prepaid expenses   149,919     
Total Current Assets   933,632    25,000 
           
Deferred offering costs       28,000 
Cash and marketable securities held in Trust Account   80,095,253     
TOTAL ASSETS  $81,028,885   $53,000 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY          
Current liabilities          
Accrued expenses  $21,787   $1,000 
Accrued offering costs       28,000 
Total Liabilities   21,787    29,000 
           
Commitments and Contingencies          
           
Common stock subject to possible redemption, 7,600,709 shares at $10.00 per share   76,007,090     
           
Stockholders’ Equity          
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; no shares issued and outstanding        
Common stock, $0.0001 par value; 30,000,000 shares authorized; 2,564,582 and 2,156,250 shares issued and outstanding (excluding 7,600,709 and no shares subject to possible redemption) at December 31, 2020 and June 30, 2020, respectively   256    216 
Additional paid-in capital   5,081,375    24,784 
Accumulated deficit   (81,623)   (1,000)
Total Stockholders’ Equity   5,000,008    24,000 
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY  $81,028,885   $53,000 

 

The accompanying notes are an integral part of the unaudited condensed financial statements.

 

1 

 

 

LIFESCI ACQUISITION II CORP.
CONDENSED STATEMENTS OF OPERATIONS

(Unaudited)

 

   Three Months Ended
December 31,
   Six Months
Ended
December 31,
   For the Period
from
December 18,
2019
(inception)
Through
December 31,
 
   2020   2020   2019 
Formation and operating costs  $85,384   $85,464   $1,000 
Loss from operations   (85,384)   (85,464)   (1,000)
                
Other income:               
Interest earned on marketable securities held in Trust Account   4,841    4,841     
                
Net Loss  $(80,543)  $(80,623)  $(1,000)
                
Weighted average shares outstanding of redeemable common stock   8,009,041    8,009,041     
Basic and diluted net loss per common share  $0.00   $0.00   $0.00 
                
Weighted average shares outstanding of non-redeemable common stock   1,875,000    1,875,000     
Basic and diluted net loss per common share  $(0.04)  $(0.04)  $(0.00)

 

The accompanying notes are an integral part of the unaudited condensed financial statements.

 

2 

 

 

LIFESCI ACQUISITION II CORP.

CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

(Unaudited)

 

THREE AND SIX MONTHS ENDED DECEMER 31, 2020

 

   Common Stock  

Additional

Paid in

   Accumulated  

Total

Stockholders’

 
    Shares    Amount    Capital    Deficit    Equity 
Balance — July 1, 2020   2,156,250   $216   $24,784   $(1,000)  $24,000 
                          
Net loss               (80)   (80)
                          
Balance — September 30, 2020   2,156,250    216    24,784    (1,080)   23,920 
                          
Sale of 8,009,041 Public Shares, net of underwriting discounts and offering costs   8,009,041    801    78,231,111        78,231,912 
                          
Sale of 3,146,454 Private Warrants           2,831,809        2,831,809 
                          
Common stock subject to possible redemption   (7,600,709)   (761)   (76,006,329)       (76,007,090)
                          
Net loss               (80,543)   (80,543)
                          
Balance — December 31, 2020   2,564,582   $256   $5,081,375   $(81,623)  $5,000,008 

 

FOR THE PERIOD FROM DECEMBER 18, 2019 (INCEPTION) THROUGH DECEMBER 31, 2019

 

   Common Stock  

Additional

Paid in

   Accumulated  

Total

Stockholder’s

 
   Shares   Amount   Capital   Deficit   Deficit 
Balance — December 18, 2019 (inception)      $   $   $   $ 
                          
Net loss               (1,000)   (1,000)
                          
Balance — December 31, 2019      $   $   $(1,000)  $(1,000)

 

The accompanying notes are an integral part of the unaudited condensed financial statements.

 

3 

 

 

LIFESCI ACQUISITION II CORP.

CONDENSED STATEMENTS OF CASH FLOWS

(Unaudited)

 

  

For the
Six Months
Ended
December 31,

  

For the Period
from
December
18, 2019
(Inception)
Through
December 31,

 
   2020   2019 
Cash Flows from Operating Activities:          
Net loss  $(80,623)  $(1,000)
Adjustments to reconcile net loss to net cash used in operating activities:          
Interest earned on marketable securities held in Trust Account   (4,841)    
Changes in operating assets and liabilities:          
Prepaid expenses   (149,919)    
Accrued expenses   20,787    1,000 
Net cash used in operating activities   (214,596)    
           
Cash Flows from Investing Activities:          
Investment of cash in Trust Account   (80,090,412)    
Net cash used in investing activities   (80,090,412)    
           
Cash Flows from Financing Activities:          
Proceeds from sale of Public Shares, net of underwriting discounts paid   78,488,602     
Proceeds from sale of Private Warrants   2,831,809     
Proceeds from promissory note – related party   175,000     
Repayment of promissory note – related party   (175,000)    
Payments of offering costs   (256,690)    
Net cash provided by financing activities   81,063,721     
           
Net Change in Cash   758,713     
Cash – Beginning   25,000     
Cash – Ending  $783,713   $ 
           
Non-Cash Investing and Financing Activities:          
Initial classification of common stock subject to possible redemption  $76,087,640   $ 
Change in value of common stock subject to possible redemption  $(80,550)  $ 
Offering costs included in accrued offering costs  $151,430   $ 

 

The accompanying notes are an integral part of the unaudited condensed financial statements.

 

4 

 

 

LIFESCI ACQUISITION II CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

DECEMBER 31, 2020

(Unaudited)

 

NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS

 

LifeSci Acquisition II Corp. (the “Company”) was incorporated in Delaware on December 18, 2019. The Company was formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business transaction with one or more businesses or entities that the Company has not yet identified (a “Business Combination”).

 

Although the Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination, the Company intends to focus on businesses operating in North America in the healthcare industry. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.

 

As of December 31, 2020, the Company had not commenced any operations. All activity through December 31, 2020 relates to the Company’s formation and the initial public offering (“Initial Public Offering”), which is described below, and identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering.

 

The registration statement for the Company’s Initial Public Offering was declared effective on November 20, 2020. On November 24, 2020 the Company consummated the Initial Public Offering of 8,009,041 shares of common stock (the “Public Shares”), which includes the partial exercise by the underwriter of its over-allotment option in the amount of 509,041 Public Shares, at $10.00 per Public Share, generating gross proceeds of $80,090,410 which is described in Note 3.

 

Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 3,146,454 warrants (the “Private Warrants”) at a price of $0.90 per Private Warrant in a private placement to LifeSci Holdings, LLC (the “Sponsor”), an entity affiliated LifeSci Capital LLC, generating gross proceeds of $2,831,809, which is described in Note 4.

 

Transaction costs amounted to $1,858,498, consisting of $1,601,808 in cash underwriting fees and $256,690 of other offering costs.

 

Following the closing of the Initial Public Offering on November 24, 2020, an amount of $80,090,410 ($10.00 per Public Share) from the net proceeds of the sale of the Public Shares in the Initial Public Offering and the sale of the Private Warrants was placed in a trust account (the “Trust Account”), and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended, or the Investment Company Act, with a maturity of 183 days or less or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the consummation of a Business Combination or (ii) the distribution of the funds in the Trust Account as described below.

 

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Warrants, although substantially all of the net proceeds are intended to be applied toward consummating a Business Combination. The Company’s initial Business Combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the balance in the Trust Account (net of amounts previously released to the Company to pay its tax obligations and for working capital purposes, subject to an annual limit of $250,000) at the time of the signing an agreement to enter into a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully effect a Business Combination.

 

The Company will provide its stockholders with the opportunity to redeem all or a portion of their Public Shares sold in the Initial Public Offering upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then on deposit in the Trust Account (initially $10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations or for working capital purposes).

 

5 

 

 

LIFESCI ACQUISITION II CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

DECEMBER 31, 2020

(Unaudited)

 

The Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the outstanding shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation, conduct the redemptions pursuant to the tender offer rules of the Securities and Exchange Commission (“SEC”), and file tender offer documents with the SEC prior to completing a Business Combination. If, however, a stockholder approval of the transaction is required by law, or the Company decides to obtain stockholder approval for business or other legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Sponsor and other initial stockholders (collectively, the “Initial Stockholders”) have agreed to (a) vote their Founder Shares (as defined in Note 5), and any Public Shares held by them in favor of a Business Combination and (b) not to convert any shares (including Founder Shares) in connection with a stockholder vote to approve a Business Combination or sell any such shares to the Company in a tender offer in connection with a Business Combination. Additionally, each public stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction.

 

Notwithstanding the foregoing, if the Company seeks stockholder approval of a Business Combination and the Company does not conduct redemptions pursuant to the tender offer rules, a stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined in Section 13(d)(3) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming their shares with respect to more than an aggregate of 20% of the Public Shares.

 

The Company will have until November 24, 2022 to consummate a Business Combination (the “Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than five business days thereafter, redeem 100% of the outstanding Public Shares, at a per share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned (net of taxes payable), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the Company’s board of directors, proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to its obligations to provide for claims of creditors and the requirements of applicable law. The proceeds deposited in the Trust Account could, however, become subject to claims of creditors.

 

The Sponsor and Chardan Healthcare Investments LLC have agreed to (i) waive their redemption rights with respect to Founder Shares and any Public Shares they may acquire during or after the Initial Public Offering in connection with the consummation of a Business Combination, (ii) to waive their rights to liquidating distributions from the Trust Account with respect to their Founder Shares if the Company fails to consummate a Business Combination within the Combination Period and (iii) not to propose an amendment to the Company’s Amended and Restated Certificate of Incorporation that would affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the public stockholders an opportunity to redeem their Public Shares in conjunction with any such amendment. However, the Sponsor will be entitled to liquidating distributions with respect to any Public Shares acquired if the Company fails to consummate a Business Combination or liquidates within the Combination Period.

 

In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below $10.00 per share, except as to any claims by a third party who executed a waiver of any right, title, interest or claim of any kind in or to any monies held in the Trust Account or to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

 

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

 

6 

 

 

LIFESCI ACQUISITION II CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

DECEMBER 31, 2020

(Unaudited)

 

The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s prospectus for its Initial Public Offering as filed with the SEC on November 23, 2020, as well as the Company’s Current Reports on Form 8-K, as filed with the SEC on November 25, 2020, and December 1, 2020. The interim results for the three and six months ended December 31, 2020 are not necessarily indicative of the results to be expected for the year ending June 30, 2021 or for any future interim periods.

 

Emerging Growth Company

 

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.

 

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

 

Use of Estimates

 

The preparation of the unaudited condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods.

 

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

 

Cash and Cash Equivalents

 

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of December 31, 2020 and June 30, 2020.

 

Common Stock Subject to Possible Redemption

 

The Company accounts for its common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at December 31, 2020, common stock subject to possible redemption are presented as temporary equity, outside of the stockholders’ equity section of the Company’s unaudited condensed balance sheet.

 

7 

 

 

LIFESCI ACQUISITION II CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

DECEMBER 31, 2020

(Unaudited)

 

Offering Costs

 

Offering costs consist of legal, accounting, underwriting fees and other costs incurred through the balance sheet date that are directly related to the Initial Public Offering. Offering costs amounting to $1,858,498 were charged to stockholders’ equity upon the completion of the Initial Public Offering.

 

Income Taxes

 

The Company complies with the accounting and reporting requirements of ASC Topic 740 “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. As of December 31, 2020, the Company had a deferred tax asset of approximately $17,000, which had a full valuation allowance recorded against it of approximately $17,000.

 

The Company’s currently taxable income primarily consists of interest income on the Trust Account. The Company’s general and administrative costs are generally considered start-up costs and are not currently deductible. During the three and six months ended December 31, 2020 the Company recorded no income tax expense. The Company’s effective tax rate for the three and six months ended December 31, 2020 was zero, which differs from the expected income tax rate due to the start-up costs which are not currently deductible.

 

ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2020 and June 30, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

 

The Company may be subject to potential examination by federal, state and city taxing authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal, state and city tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. The Company is subject to income tax examinations by major taxing authorities since inception.

 

Net Loss Per Common Share

 

Net loss per common share is computed by dividing net loss by the weighted average number of common shares outstanding for the period. The Company has not considered the effect of warrants sold in connection with the private placement to purchase 3,146,454 shares of common stock in the calculation of diluted loss per common share, since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive under the treasury stock method.

 

The Company’s unaudited condensed statements of operations includes a presentation of loss per share for common shares subject to possible redemption in a manner similar to the two-class method of loss per share. Net income per common share, basic and diluted, for redeemable common stock is calculated by dividing the interest income earned on the Trust Account, less applicable franchise and income taxes, by the weighted average number of redeemable common stock outstanding for the period. Net loss per common share, basic and diluted, for non-redeemable common stock is calculated by dividing the net loss, less income attributable to redeemable common stock, by the weighted average number of non-redeemable common stock outstanding for the period. Weighted average shares were reduced for the effect of an aggregate of 281,250 shares of common stock that were subject to forfeiture if the over-allotment option was not exercised by the underwriters. Non-redeemable common stock includes the Founder Shares as these shares do not have any redemption features and do not participate in the income earned on the Trust Account.

 

8 

 

 

LIFESCI ACQUISITION II CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

DECEMBER 31, 2020

(Unaudited)

 

The following table reflects the calculation of basic and diluted net loss per common share (in dollars, except per share amounts):

 

  Three Months
Ended
December 31,
   Six Months
Ended
December 31,
  

For the Period
from
December 18,
2019
(inception)
Through
December 31,

 
   2020   2020   2019 
Redeemable Common Stock             
Numerator: Earnings allocable to Redeemable Common Stock             
Interest Income  $4,841   $4,841   $ 
Income and Franchise Tax   (4,841)   (4,841)    
Net Earnings  $   $   $ 
Denominator: Weighted Average Redeemable Common Stock            
Redeemable Common Stock, Basic and Diluted   8,009,041    8,009,041     
Earnings/Basic and Diluted Redeemable Common Stock  $0.00   $0.00   $0.00 
                
Non-Redeemable Common Stock            
Numerator: Net Loss minus Redeemable Net Earnings            

Net Loss

  $(80,543)  $(80,623)  $(1,000)
Redeemable Net Earnings            
Non-Redeemable Net Loss  $(80,543)  $(80,623)  $(1,000)
Denominator: Weighted Average Non-Redeemable Common Stock            
Non-Redeemable Common Stock, Basic and Diluted   1,875,000    

1,875,000

     
Loss/Basic and Diluted Non-Redeemable Common Stock  $(0.04)  $(0.04)  $(0.00)

 

Note: As of December 31, 2020, basic and diluted shares are the same as there are no non-redeemable securities that are dilutive to the Company’s stockholders.

 

Concentration of Credit Risk

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.

 

Fair Value of Financial Instruments

 

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying unaudited condensed balance sheets, primarily due to their short-term nature.

 

Recent Accounting Pronouncements

 

Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.

 

NOTE 3. PUBLIC OFFERING

 

Pursuant to the Initial Public Offering, the Company sold 8,009,041 Public Shares, which includes the partial exercise by the underwriters of their over-allotment option in the amount of 509,041 Public Shares, at a purchase price of $10.00 per Public Share.

 

NOTE 4. PRIVATE PLACEMENT

 

Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 3,146,454 Private Warrants at a price of $0.90 per Private Warrant for an aggregate purchase price of $2,831,809. Each Private Warrant is exercisable to purchase one share of common stock at an exercise price of $11.50 per warrant. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law). There will be no redemption rights or liquidating distributions from the Trust Account with respect to the Private Warrants.

 

NOTE 5. RELATED PARTY TRANSACTIONS

 

Founder Shares

 

On January 1, 2020, the Company issued an aggregate of 2,156,250 shares of common stock (the “Founder Shares”) to the Sponsor for an aggregate purchase price of $25,000. On September 30, 2020, LifeSci Holdings LLC transferred 215,625 Founder Shares to Chardan Healthcare Investments LLC, an investor in the Sponsor. The Founder Shares included an aggregate of up to 153,990 shares of common stock that remained subject to forfeiture by the Sponsor, following the underwriters’ election to partially exercise their over-allotment option so that the number of Founder Shares would collectively represent 20% of the Company’s issued and outstanding shares upon the completion of the Initial Public Offering. On January 8, 2021, the underwriters’ election to exercise their remaining over-allotment option expired unexercised, resulting in 615,959 shares no longer subject to forfeiture and the forfeiture of 153,990 shares. Accordingly, as of January 8, 2021, there are 2,002,260 Founder Shares issued and outstanding (Note 9).

 

9 

 

 

LIFESCI ACQUISITION II CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

DECEMBER 31, 2020

(Unaudited)

 

The Sponsor and Chardan Healthcare Investments LLC have agreed that, subject to certain limited exceptions, 50% of the Founder Shares will not be transferred, assigned, sold or released from escrow until the earlier of (i) six months after the date of the consummation of a Business Combination or (ii) the date on which the closing price of the Company’s shares of common stock equals or exceeds $12.50 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations) for any 20 trading days within any 30-trading day period commencing after a Business Combination and the remaining 50% of the Founder Shares will not be transferred, assigned, sold or released from escrow until six months after the date of the consummation of a Business Combination, or earlier, in either case, if, subsequent to a Business Combination, the Company consummates a subsequent liquidation, merger, stock exchange or other similar transaction which results in all of the stockholders having the right to exchange their shares of common stock for cash, securities or other property.

 

Administrative Support Agreement

 

The Company entered into an agreement, commencing on November 20, 2020 through the earlier of the Company’s consummation of a Business Combination and its liquidation, to pay an affiliate of the Sponsor a total of $10,000 per month for office space, utilities and secretarial support. For each of the three and six months ended December 31, 2020, the Company incurred $10,000 in fees for these services, of which such amount is included in accrued expenses in the accompanying unaudited condensed balance sheets.

 

Promissory Note — Related Party

 

On June 19, 2020, the Company issued an unsecured promissory note to the Sponsor (the “Promissory Note”), pursuant to which the Company could borrow up to an aggregate principal amount of $175,000. The Promissory Note was non-interest bearing and payable within 15 days of the Sponsor providing the Company with written notice of demand. The outstanding balance under the Promissory Note of $175,000 was repaid at the closing of the Initial Public Offering on November 24, 2020.

 

Related Party Loans

 

In order to finance transaction costs in connection with a Business Combination, the Sponsor, an affiliate of the Sponsor, or the Company’s officers and directors may, but are not obligated to, loan the Company funds from time to time or at any time, as may be required (“Working Capital Loans”). Each Working Capital Loan would be evidenced by a promissory note. The Working Capital Loans would be paid upon consummation of a Business Combination, without interest or, at the lender’s discretion, up to $500,000 of such Working Capital Loans may be converted into warrants of the post Business Combination entity at a price of $0.90 per warrant. In the event that a Business Combination does not close, the Company may use a portion of the proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The warrants would be identical to the Private Warrants. As of December 31, 2020 and June 30, 2020, the Company had no outstanding borrowings under the Working Capital Loans.

 

NOTE 6. COMMITMENTS

 

Risks and Uncertainties

 

Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position and/or search for a target company, the specific impact is not readily determinable as of the date of the financial statement. The financial statement does not include any adjustments that might result from the outcome of this uncertainty.

 

Registration and Stockholder Rights

 

Pursuant to a registration rights agreement entered into on November 20, 2020, the holders of the Founder Shares and the Private Warrants and any shares that may be issued upon conversion of Working Capital Loans (and all underlying securities) will be entitled to registration and stockholder rights. The holders of a majority of these securities are entitled to make up to two demands that the Company register such securities. The holders of the majority of the Founders Warrants can elect to exercise these registration rights at any time commencing three months prior to the date on which these shares of common stock are to be released from escrow. The holders of a majority of the Private Warrants can elect to exercise these registration rights at any time after the Company consummates a Business Combination. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the consummation of a Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. The Sponsor and its related persons may not, with respect to the Private Warrants purchased by it, (i) have more than one demand registration right at the Company’s expense, (ii) exercise their demand registration rights more than five (5) years from the effective date of the registration statement of the Initial Public Offering, and (iii) exercise their “piggy-back” registration rights more than seven (7) years from the effective date of the Initial Public Offering, as long as the Sponsor or any of its related persons are beneficial owners of Private Warrants.

 

10 

 

 

LIFESCI ACQUISITION II CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

DECEMBER 31, 2020

(Unaudited)

 

Underwriting Agreement

 

The Company granted the underwriters a 45-day option from the date of the Initial Public Offering to purchase up to 1,125,000 additional Public Shares to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. As a result of the underwriter’s election to partially exercise the over-allotment option to purchase an additional 509,041 Public Shares, a total of 615,959 Public Shares remained available for purchase at a price of $10.00 per Public Share. On January 8, 2021, the underwriters’ election to exercise their remaining over-allotment option expired unexercised (Note 9).

 

The underwriters were paid cash underwriting discount of $0.20 per Public Share, or $1,601,808 in the aggregate.

 

Business Combination Marketing Agreement

 

The Company has engaged LifeSci Capital LLC and Ladenburg Thalmann & Co. Inc. (“Ladenburg Thalmann “) as advisors in connection with a Business Combination to assist the Company in holding meetings with its stockholders to discuss the potential Business Combination and the target business’ attributes, introduce the Company to potential investors that are interested in purchasing the Company’s securities in connection with a Business Combination, assist the Company in obtaining stockholder approval for the Business Combination and assist the Company with its press releases and public filings in connection with the Business Combination. The Company will pay LifeSci Capital LLC and Ladenburg Thalmann a cash fee for such services upon the consummation of a Business Combination in an amount equal to 3.5% of the gross proceeds of the Initial Public Offering, or $2,803,164, (exclusive of any applicable finders’ fees which might become payable) with 75% of such fee payable to LifeSci Capital LLC and 25% to Ladenburg Thalmann; provided that up to 33% of the fee may be allocated in the Company’s sole discretion to other third parties who are investment banks or financial advisory firms not participating in Initial Public Offering that assist the Company in identifying and consummating a Business Combination.

 

NOTE 7. STOCKHOLDERS’ EQUITY

 

Preferred Stock — The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. At December 31, 2020, there were no shares of preferred stock issued or outstanding.

 

Common Stock — The Company is authorized to issue 30,000,000 shares of common stock with a par value of $0.0001 per share. Holders of the Company’s common stock are entitled to one vote for each share. At December 31, 2020, there were 2,564,582 shares of common stock issued and outstanding, excluding 7,600,709 shares of common stock subject to possible redemption.

 

Warrants —The Private Warrants will become exercisable at any time commencing on the later of (1) one year after the closing of the Initial Public Offering or (2) the consummation of a Business Combination; provided that the Company has an effective and current registration statement covering the shares of common stock issuable upon the exercise of the Public Warrants and a current prospectus relating to such shares of common stock.

 

The Private Warrants purchased by the Sponsor will be exercisable on a cashless basis and not be exercisable more than five years from the commencement of sales of the Initial Public Offering, in accordance with FINRA Rule 5110(g)(8)(A), as long as the Sponsor or any of its related persons beneficially own these Private Warrants.

 

NOTE 8. FAIR VALUE MEASUREMENTS

 

The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:

 

11 

 

 

LIFESCI ACQUISITION II CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

DECEMBER 31, 2020

(Unaudited)

 

  Level 1:  Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.
     
  Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.
     
  Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.

 

At December 31, 2020, assets held in the Trust Account were comprised of $80,095,253 in money market funds which are invested in U.S. Treasury Securities. During the six months ended December 31, 2020, the Company did not withdraw any interest income from the Trust Account.

 

The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at December 31, 2020 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:

 

Description  Level   December 31,
2020
 
Assets:          
Marketable securities held in Trust Account –Money Market Fund   1   $80,095,253 

 

NOTE 9. SUBSEQUENT EVENTS

 

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the unaudited condensed financial statements were issued. Based upon this review, other than as described below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements.

 

On January 8, 2021, the underwriters’ election to exercise their remaining over-allotment option expired unexercised, resulting in the forfeiture of 153,990 Founder Shares. Accordingly, as of January 8, 2021, there are 2,002,260 Founder Shares issued and outstanding.

 

12 

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

References in this report (the “Quarterly Report”) to “we,” “us” or the “Company” refer to LifeSci Acquisition II Corp. References to our “management” or our “management team” refer to our officers and directors, references to the “Sponsor” refer to LifeSci Holdings, LLC. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

 

Special Note Regarding Forward-Looking Statements

 

This Quarterly Report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act that are not historical facts, and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Form 10-Q including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s final prospectus for its Initial Public Offering filed with the U.S. Securities and Exchange Commission (the “SEC”). The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

 

Overview

 

We are a blank check company formed under the laws of the State of Delaware on December 18, 2019 for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar Business Combination with one or more businesses. We intend to effectuate our Business Combination using cash from the proceeds of the Initial Public Offering and the sale of the Private Warrants, our capital stock, debt or a combination of cash, stock and debt.

 

We expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a Business Combination will be successful.

 

Results of Operations

 

We have neither engaged in any operations nor generated any revenues to date. Our only activities since inception have been organizational activities, those necessary to prepare for our Initial Public Offering, and subsequent to our Initial Public Offering, identifying a target for our initial Business Combination. We do not expect to generate any operating revenues until after completion of our initial Business Combination. We generate non-operating income in the form of interest income on investments held in the Trust Account. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as expenses as we conduct due diligence on prospective Business Combination candidates.

 

For the three months ended December 31, 2020, we had a net loss of $80,543, which consists of operating costs of $85,384, offset by interest income on investments held in the Trust Account of $4,841.

 

For the six months ended December 31, 2020, we had a net loss of $80,623, which consists of operating costs of $85,464, offset by interest income on investments held in the Trust Account of $4,841.

 

For the period from December 18, 2019 (inception) through December 31, 2019, we had a net loss of $1,000, which consists of formation and operating costs.

 

Liquidity and Capital Resources

 

Until the consummation of our Initial Public Offering, our only sources of liquidity were an initial purchase of common stock by the Sponsor and loans from our Sponsor.

 

On November 24, 2020, we consummated the Initial Public Offering of 8,009,041 Public Shares, which includes the partial exercise by the underwriter of its over-allotment option in the amount of 509,041 Public Shares, at a price of $10.00 per Public Share, generating gross proceeds of $80,090,410. Simultaneously with the closing of the Initial Public Offering, we consummated the sale of 3,146,454 Private Warrants to the Sponsor at a price of $0.90 per Private Warrant, generating gross proceeds of $2,831,809.

 

13 

 

 

Following the Initial Public Offering, the partial exercise of the over-allotment option and the sale of the Private Warrants, a total of $80,090,410 was placed in the Trust Account. We incurred $1,858,498 in transaction costs, including $1,601,808 of underwriting fees and $256,690 of other costs.

 

For the six months ended December 31, 2020, cash used in operating activities was $214,596. Net loss of $80,623 was affected by interest earned on investments held in the Trust Account of $4,841 and changes in operating assets and liabilities, which used $129,132 of cash from operating activities.

 

As of December 31, 2020, we had investments of $80,095,253 held in the Trust Account. We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (less deferred underwriting commissions) to complete our initial Business Combination. We may withdraw interest to pay taxes. To the extent that our capital stock or debt is used, in whole or in part, as consideration to complete our initial Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.

 

As of December 31, 2020, we had cash of $783,713 outside of the Trust Account. We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete our initial Business Combination.

 

In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsors, or an affiliate of the Sponsor, or certain of the Company’s officers and directors or their affiliates may, but are not obligated to, loan us funds as may be required. Each Working Capital Loan would be evidenced by a promissory note. If we complete a Business Combination, we would repay the Working Capital Loans out of the proceeds of the Trust Account released to us. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, we may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $500,000 of such Working Capital Loans may be convertible into warrants of the post Business Combination entity. The warrants would be identical to the Private Warrants.

 

Off-Balance Sheet Financing Arrangements

 

We have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of December 31, 2020. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.

 

Contractual Obligations

 

We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than an agreement to pay an affiliate of the Sponsor a monthly fee of $10,000 for office space, utilities and secretarial support to the Company. We began incurring these fees on November 20, 2020 and will continue to incur these fees monthly until the earlier of the completion of the Business Combination and the Company’s liquidation.

 

Critical Accounting Policies

 

The preparation of condensed financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following critical accounting policies:

 

Common Stock Subject to Possible Redemption

 

We account for our common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. Our common stock features certain redemption rights that are considered to be outside of our control and subject to occurrence of uncertain future events. Accordingly, the common stock subject to possible redemption is presented as temporary equity, outside of the stockholders’ equity section of our condensed balance sheets.

 

14 

 

 

Net Loss per Common Share

 

We apply the two-class method in calculating earnings per share. Shares of common stock subject to possible redemption which are not currently redeemable and are not redeemable at fair value, have been excluded from the calculation of basic net loss per share since such shares, if redeemed, only participate in their pro rata share of the Trust Account earnings. Our net income is adjusted for the portion of income that is attributable to common stock subject to possible redemption, as these shares only participate in the earnings of the Trust Account and not our income or losses.

 

Recent Accounting Standards

 

Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on our condensed financial statements.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

As of December 31, 2020, we were not subject to any market or interest rate risk. Following the consummation of our Initial Public Offering, the net proceeds received into the Trust Account, have been invested in U.S. government treasury bills, notes or bonds with a maturity of 183 days or less or in certain money market funds that invest solely in US treasuries. Due to the short-term nature of these investments, we believe there will be no associated material exposure to interest rate risk.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

 

Evaluation of Disclosure Controls and Procedures

 

As required by Rules 13a-15 and 15d-15 under the Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of December 31, 2020. Based upon their evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures (as defined in Rules 13a-15 (e) and 15d-15 (e) under the Exchange Act) were effective.

 

Changes in Internal Control Over Financial Reporting

 

During the most recently completed fiscal quarter, there has been no change in our internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

PART II - OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS.

 

None.

 

ITEM 1A. RISK FACTORS.

 

Factors that could cause our actual results to differ materially from those in this Quarterly Report include the risk factors described in our final prospectus filed with the SEC on November 23, 2020. As of the date of this Quarterly Report, there have been no material changes to the risk factors disclosed in our final prospectus filed with the SEC.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

 

On November 24, 2020, we consummated our Initial Public Offering of 8,009,041 Public Shares, which includes the partially exercise by the underwriters of their over-allotment option in the amount of 509,041 Public Shares. The Public Shares were sold at an offering price of $10.00 per Public Share, generating total gross proceeds of $80,090,410. LifeSci Capital LLC and Ladenburg Thalmann & Co. Inc. acted as joint book running managers of the offering. The securities sold in the offering were registered under the Securities Act on registration statements on Form S-1 (No. 333-249480). The SEC declared the registration statements effective on November 20, 2020.

 

15 

 

 

Simultaneously with the consummation of the Initial Public Offering and the partial exercise of the over-allotment option, we consummated a private placement of 3,146,454 Private Warrants to LifeSci Holdings, LLC at a price of $0.90 per Private Warrant, generating total proceeds of $2,831,809. Such securities were issued pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.

 

Of the gross proceeds received from the Initial Public Offering, the partial exercise of the over-allotment option and the Private Warrants, $80,090,410 was placed in the Trust Account.

 

We paid a total of $1,601,808 underwriting discounts and commissions and $256,690 for other costs and expenses related to the Initial Public Offering.

 

For a description of the use of the proceeds generated in our Initial Public Offering, see Part I, Item 2 of this Form 10-Q.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES.

 

Not applicable.

 

ITEM 5. OTHER INFORMATION.

 

None.

 

ITEM 6. EXHIBITS.

 

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.

 

No.   Description of Exhibit
1.1   Underwriting Agreement, dated November 20, 2020, by and between the Registrant and LifeSci Capital LLC and Ladenburg Thalmann & Co. Inc. (1)
1.2   Business Combination Marketing Agreement, dated November 20, 2020, by and between the Company and LifeSci Capital LLC and Ladenburg Thalmann & Co. Inc. (1)
3.1   Amended and Restated Certificate of Incorporation. (1)
4.1   Private Warrant Agreement, dated November 24, 2020. (1)
10.1   Letter Agreements, dated November 20, 2020, among the Registrant and the Registrant’s officers, directors and Initial Stockholders. (1)
10.2   Investment Management Trust Agreement, dated November 20, 2020, by and between Continental Stock Transfer & Trust Company and the Registrant. (1)
10.3   Stock Escrow Agreement, dated November 20, 2020, among the Registrant, Continental Stock Transfer & Trust Company and the Initial Stockholders. (1)
10.4   Registration and Stockholder Rights Agreement, dated November 20, 2020, by and between the Registrant and Initial Stockholders. (1)
10.5   Subscription Agreement, dated November 20, 2020, by and between the Registrant and LifeSci Holdings LLC. (1)
10.6   Administrative Services Agreement, dated November 20, 2020, by and between the Registrant and LifeSci Capital LLC. (1)
31.1*   Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*   Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1**   Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2**   Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS*   XBRL Instance Document
101.CAL*   XBRL Taxonomy Extension Calculation Linkbase Document
101.SCH*   XBRL Taxonomy Extension Schema Document

 

16 

 

 

101.DEF*   XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*   XBRL Taxonomy Extension Labels Linkbase Document
101.PRE*   XBRL Taxonomy Extension Presentation Linkbase Document

 

(1) Previously filed as an exhibit to our Current Report on Form 8-K filed on November 25, 2020.
* Filed herewith.
** Furnished.

 

17 

 

 

SIGNATURES

 

Pursuant to the requirements of Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  LIFESCI ACQUISITION II CORP.
     
Date: February 2, 2021   /s/ Andrew McDonald
  Name: Andrew McDonald
  Title: Chief Executive Officer
    (Principal Executive Officer)
     
Date: February 2, 2021   /s/ David Dobkin
  Name: David Dobkin
  Title: Chief Financial Officer
    (Principal Financial and Accounting Officer)

 

18 

 

EX-31.1 2 tm214486d1_ex31-1.htm EXHIBIT 31.1

 

Exhibit 31.1

 

CERTIFICATIONS

 

I, Andrew McDonald, certify that:

 

  1. I have reviewed this Quarterly Report on Form 10-Q of LifeSci Acquisition II Corp.;

 

  2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

  3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

  4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

 

  a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  b) (Paragraph omitted pursuant to SEC Release Nos. 33-8238/34-47986 and 33-8392/34-49313);

 

  c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

  5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: February 2, 2021 By: /s/ Andrew McDonald
  Name: Andrew McDonald
  Title: Chief Executive Officer
    (Principal Executive Officer)

 

 

EX-31.2 3 tm214486d1_ex31-2.htm EXHIBIT 31.2

 

Exhibit 31.2

 

CERTIFICATIONS

 

I, David Dobkin, certify that:

 

  1. I have reviewed this Quarterly Report on Form 10-Q of LifeSci Acquisition II Corp.;

 

  2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

  3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

  4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

 

  a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  b) (Paragraph omitted pursuant to SEC Release Nos. 33-8238/34-47986 and 33-8392/34-49313);

 

  c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

  5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: February 2, 2021 By: /s/ David Dobkin
  Name: David Dobkin
  Title: Chief Financial Officer
    (Principal Financial and Accounting Officer)

 

 

EX-32.1 4 tm214486d1_ex32-1.htm EXHIBIT 32.1

 

Exhibit 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADDED BY

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of LifeSci Acquisition II Corp. (the “Company”) on Form 10-Q for the quarterly period ended December 31, 2020, as filed with the Securities and Exchange Commission (the “Report”), I, Andrew McDonald, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as added by §906 of the Sarbanes-Oxley Act of 2002, that:

 

  1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  2. To my knowledge, the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by the Report.

 

Date: February 2, 2021 By: /s/ Andrew McDonald
  Name: Andrew McDonald
  Title: Chief Executive Officer
    (Principal Executive Officer)

 

 

EX-32.2 5 tm214486d1_ex32-2.htm EXHIBIT 32.2

 

Exhibit 32.2

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADDED BY

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of LifeSci Acquisition II Corp. (the “Company”) on Form 10-Q for the quarterly period ended December 31, 2020, as filed with the Securities and Exchange Commission (the “Report”), I, David Dobkin, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as added by §906 of the Sarbanes-Oxley Act of 2002, that:

 

  1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  2. To my knowledge, the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by the Report.

 

Date: February 2, 2021 By: /s/ David Dobkin
  Name: David Dobkin
  Title: Chief Financial Officer
    (Principal Financial and Accounting Officer)

 

 

EX-101.INS 6 lsaq-20201231.xml XBRL INSTANCE DOCUMENT 0001819113 us-gaap:WarrantMember 2020-12-31 0001819113 us-gaap:CommonClassAMember 2020-12-31 0001819113 isaq:FounderSharesMember isaq:SponsorMember 2020-09-30 2020-09-30 0001819113 isaq:FounderSharesMember isaq:SponsorMember 2020-01-01 2020-01-01 0001819113 us-gaap:RetainedEarningsMember 2020-12-31 0001819113 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001819113 us-gaap:RetainedEarningsMember 2020-09-30 0001819113 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0001819113 2020-09-30 0001819113 us-gaap:RetainedEarningsMember 2020-06-30 0001819113 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001819113 us-gaap:CommonStockMember 2020-12-31 0001819113 us-gaap:CommonStockMember 2020-09-30 0001819113 us-gaap:CommonStockMember 2020-06-30 0001819113 us-gaap:IPOMember 2020-11-24 0001819113 us-gaap:RetainedEarningsMember 2020-10-01 2020-12-31 0001819113 us-gaap:RetainedEarningsMember 2020-07-01 2020-09-30 0001819113 2020-07-01 2020-09-30 0001819113 2019-12-19 2019-12-31 0001819113 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001819113 isaq:RedeemableCommonStockMember 2019-12-18 2019-12-31 0001819113 isaq:RelatedPartyLoansMember 2020-06-30 0001819113 2020-11-24 0001819113 us-gaap:PrivatePlacementMember 2020-11-24 0001819113 2019-12-31 0001819113 2019-12-17 0001819113 us-gaap:WarrantMember 2020-07-01 2020-12-31 0001819113 us-gaap:WarrantMember 2020-07-01 2020-12-31 0001819113 us-gaap:OverAllotmentOptionMember 2020-11-24 2020-11-24 0001819113 us-gaap:OverAllotmentOptionMember 2020-07-01 2020-12-31 0001819113 isaq:RemainingFiftyPercentOfSharesMember isaq:FounderSharesMember 2020-01-01 0001819113 isaq:FirstFiftyPercentOfSharesMember isaq:FounderSharesMember 2020-01-01 0001819113 isaq:FirstFiftyPercentOfSharesMember isaq:FounderSharesMember 2020-01-01 2020-01-01 0001819113 2020-11-24 2020-11-24 0001819113 isaq:AdministrativeSupportAgreementMember 2020-11-20 2020-11-20 0001819113 us-gaap:IPOMember 2020-11-24 2020-11-24 0001819113 isaq:PromissoryNoteWithRelatedPartyMember 2020-06-19 2020-06-19 0001819113 isaq:FounderSharesMember 2020-01-01 2020-01-01 0001819113 isaq:LadenburgThalmannMember 2020-07-01 2020-12-31 0001819113 us-gaap:OverAllotmentOptionMember 2020-12-31 0001819113 isaq:FounderSharesMember isaq:SponsorMember us-gaap:SubsequentEventMember 2021-01-08 2021-01-08 0001819113 isaq:NonRedeemableCommonStockMember 2020-10-01 2020-12-31 0001819113 isaq:NonRedeemableCommonStockMember 2020-07-01 2020-12-31 0001819113 isaq:NonRedeemableCommonStockMember 2019-12-18 2019-12-31 0001819113 isaq:RelatedPartyLoansMember 2020-12-31 0001819113 isaq:FounderSharesMember isaq:SponsorMember 2020-01-01 0001819113 isaq:RedeemableCommonStockMember 2020-10-01 2020-12-31 0001819113 isaq:RedeemableCommonStockMember 2020-07-01 2020-12-31 0001819113 isaq:FounderSharesMember us-gaap:SubsequentEventMember us-gaap:OverAllotmentOptionMember 2021-01-08 0001819113 isaq:FounderSharesMember us-gaap:SubsequentEventMember 2021-01-08 0001819113 us-gaap:PrivatePlacementMember 2020-11-24 2020-11-24 0001819113 us-gaap:CommonStockMember 2020-10-01 2020-12-31 0001819113 us-gaap:AdditionalPaidInCapitalMember 2020-10-01 2020-12-31 0001819113 2020-10-01 2020-12-31 0001819113 2019-12-18 2019-12-31 0001819113 isaq:LifesciCapitalLlcMember 2020-07-01 2020-12-31 0001819113 2020-12-31 0001819113 2020-06-30 0001819113 2021-01-29 0001819113 2020-07-01 2020-12-31 isaq:item isaq:Vote iso4217:USD xbrli:shares xbrli:pure iso4217:USD xbrli:shares false --06-30 Q2 2021 2020-12-31 10-Q 0001819113 10011301 Yes true false Non-accelerated Filer Yes Lifesci Acquisition II Corp. true true Shares of Common Stock, $0.0001 par value NASDAQ LSAQ 1000 21787 28000 0.035 0 -80550 76007090 76006329 761 7600709 0.90 0.90 1 153990 153990 <div> <div> <p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"> <font style="display:inline;">Common Stock Subject to Possible Redemption</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The Company accounts for its common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (&#x201C;ASC&#x201D;) Topic 480 &#x201C;Distinguishing Liabilities from Equity.&#x201D; Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&#x2019;s control) is classified as temporary equity. At all other times, common stock is classified as stockholders&#x2019; equity. The Company&#x2019;s common stock features certain redemption rights that are considered to be outside of the Company&#x2019;s control and subject to occurrence of uncertain future events. Accordingly, at December&nbsp;31, 2020, common stock subject to possible redemption are presented as temporary equity, outside of the stockholders&#x2019; equity section of the Company&#x2019;s &nbsp;unaudited condensed balance sheet.</font> </p><div /></div> </div> 0.20 1601808 <div> <div> <p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"> <font style="display:inline;">Emerging Growth Company</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The Company is an &#x201C;emerging growth company,&#x201D; as defined in Section&nbsp;2(a)&nbsp;of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the &#x201C;JOBS Act&#x201D;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section&nbsp;404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">Further, Section&nbsp;102(b)(1)&nbsp;of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#x2019;s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</font> </p><div /></div> </div> 250000 -1000 -85464 -85384 -4841 -4841 0 76087640 <div> <div> <p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"> <font style="display:inline;">NOTE&nbsp;3. PUBLIC OFFERING</font> </p> <p style="margin:0pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">Pursuant to the Initial Public Offering, the Company sold 8,009,041 Public Shares, which includes the partial exercise by the underwriters of their over-allotment option in the amount of 509,041 Public Shares, at a purchase price of $10.00 per Public Share.</font> </p><div /></div> </div> 0 80090412 153990 500000 5000001 -1000 -80623 -80543 615959 615959 <div> <div> <p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"> <font style="display:inline;">Offering Costs</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">Offering costs consist of legal, accounting, underwriting fees and other costs incurred through the balance sheet date that are directly related to the Initial Public Offering. Offering costs amounting to $1,858,498 were charged to stockholders&#x2019; equity upon the completion of the Initial Public Offering.</font> </p><div /></div> </div> 1.00 0.25 0.75 0.33 0.20 P15D <div> <div> <p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"> <font style="display:inline;">NOTE&nbsp;4. PRIVATE PLACEMENT</font> </p> <p style="margin:0pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 3,146,454 Private Warrants at a price of $0.90 per Private Warrant for an aggregate purchase price of $2,831,809. Each Private Warrant is exercisable to purchase one share of common stock at an exercise price of $11.50 per warrant. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law). There will be no redemption rights or liquidating distributions from the Trust Account with respect to the Private Warrants.</font> </p><div /></div> </div> 80090410 80090410 2 1 P7Y P3M P5Y 10000 256690 1858498 1601808 P5D 0.80 0.50 0.20 P6M 1858498 12.50 30 20 0.50 0.50 true 10.00 509041 8009041 8009041 509041 509041 P1Y 3146454 0.90 281250 250000 24784 5081375 2831809 2831809 3146454 53000 81028885 25000 933632 80095253 80095253 <div> <div> <p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"> <font style="display:inline;">Basis of Presentation</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201C;GAAP&#x201D;) for interim financial information and in accordance with the instructions to Form&nbsp;10&#8209;Q and Article&nbsp;8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules&nbsp;and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The accompanying unaudited condensed financial statements should be read in conjunction with the Company&#x2019;s prospectus for its Initial Public Offering as filed with the SEC on November&nbsp;23, 2020, as well as the Company&#x2019;s Current Reports on Form&nbsp;8&#8209;K, as filed with the SEC on November&nbsp;25, 2020, and December&nbsp;1, 2020. The interim results for the three and six&nbsp;months ended December&nbsp;31, 2020 are not necessarily indicative of the results to be expected for the&nbsp;year ending June&nbsp;30, 2021 or for any future interim periods.</font> </p><div /></div> </div> 0 151430 25000 783713 <div> <div> <p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"> <font style="display:inline;">Cash and Cash Equivalents</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The Company considers all short-term investments with an original maturity of three&nbsp;months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of December&nbsp;31, 2020 and June&nbsp;30, 2020.</font> </p><div /></div> </div> 0 0 25000 783713 0 758713 11.50 1 3146454 3146454 <div> <div> <p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"> <font style="display:inline;">NOTE&nbsp;6. COMMITMENTS</font> </p> <p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"> <font style="display:inline;">Risks and Uncertainties</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">Management continues to evaluate the impact of the COVID&#8209;19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company&#x2019;s financial position and/or search for a target company, the specific impact is not readily determinable as of the date of the financial statement. The financial statement does not include any adjustments that might result from the outcome of this uncertainty.</font> </p> <p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"> <font style="display:inline;">Registration and Stockholder Rights</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">Pursuant to a registration rights agreement entered into on November&nbsp;20, 2020, the holders of the Founder Shares and the Private Warrants and any shares that may be issued upon conversion of Working Capital Loans (and all underlying securities) will be entitled to registration and stockholder rights. The holders of a majority of these securities are entitled to make up to two demands that the Company register such securities. The holders of the majority of the Founders Warrants can elect to exercise these registration rights at any time commencing three&nbsp;months prior to the date on which these shares of common stock are to be released from escrow. The holders of a majority of the Private Warrants can elect to exercise these registration rights at any time after the Company consummates a Business Combination. In addition, the holders have certain &#x201C;piggy-back&#x201D; registration rights with respect to registration statements filed subsequent to the consummation of a Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. The Sponsor and its related persons may not, with respect to the Private Warrants purchased by it, (i)&nbsp;have more than one demand registration right at the Company&#x2019;s expense, (ii)&nbsp;exercise their demand registration rights more than five&nbsp;(5)&nbsp;years from the effective date of the registration statement of the Initial Public Offering, and (iii)&nbsp;exercise their &#x201C;piggy-back&#x201D; registration rights more than seven&nbsp;(7)&nbsp;years from the effective date of the Initial Public Offering, as long as the Sponsor or any of its related persons are beneficial owners of Private Warrants.</font> </p> <p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"> <font style="display:inline;">Underwriting Agreement</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The Company granted the underwriters a 45&#8209;day option from the date of the Initial Public Offering to purchase up to 1,125,000 additional Public Shares to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. As a result of the underwriter&#x2019;s election to partially exercise the over-allotment option to purchase an additional 509,041 Public Shares, a total of 615,959 Public Shares remained available for purchase at a price of $10.00 per Public S<a name="_Hlk62733615"></a>hare. On January&nbsp;8, 2021, the underwriters&#x2019; election to exercise their remaining over-allotment option expired unexercised (Note&nbsp;9).</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The underwriters were paid cash underwriting discount of $0.20 per Public Share, or $1,601,808 in the aggregate.</font> </p> <p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"> <font style="display:inline;">Business Combination Marketing Agreement</font> </p> <p style="margin:0pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The Company has engaged LifeSci Capital LLC and Ladenburg Thalmann&nbsp;&amp; Co.&nbsp;Inc. (&#x201C;Ladenburg Thalmann &#x201C;) as advisors in connection with a Business Combination to assist the Company in holding meetings with its stockholders to discuss the potential Business Combination and the target business&#x2019; attributes, introduce the Company to potential investors that are interested in purchasing the Company&#x2019;s securities in connection with a Business Combination, assist the Company in obtaining stockholder approval for the Business Combination and assist the Company with its press releases and public filings in connection with the Business Combination. The Company will pay LifeSci Capital LLC and Ladenburg Thalmann a cash fee for such services upon the consummation of a Business Combination in an amount equal to 3.5% of the gross proceeds of the Initial Public Offering, or $2,803,164, (exclusive of any applicable finders&#x2019; fees which might become payable) with 75% of such fee payable to LifeSci Capital LLC and 25% to Ladenburg Thalmann; provided that up to 33% of the fee may be allocated in the Company&#x2019;s sole discretion to other third parties who are investment banks or financial advisory firms not participating in Initial Public Offering that assist the Company in identifying and consummating a Business Combination.</font> </p><div /></div> </div> 0.0001 0.0001 0.0001 30000000 30000000 30000000 1125000 2156250 2564582 2564582 2002260 2002260 2156250 2564582 2002260 2002260 216 256 <div> <div> <p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"> <font style="display:inline;">Concentration of Credit Risk</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</font> </p><div /></div> </div> 28000 17000 17000 0 0 0.00 0.00 0.00 -0.04 -0.04 0.00 -0.04 -0.04 0.00 <div> <div> <p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"> <font style="display:inline;">Net Loss Per Common Share</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">Net loss per common share is computed by dividing net loss by the weighted average number of common shares outstanding for the period. The Company has not considered the effect of warrants sold in connection with the private placement to purchase 3,146,454 shares of common stock in the calculation of diluted loss per common share, since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive under the treasury stock method.</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The Company&#x2019;s &nbsp;unaudited condensed statements of operations includes a presentation of loss per share for common shares subject to possible redemption in a manner similar to the two-class method of loss per share. Net income per common share, basic and diluted, for redeemable common stock is calculated by dividing the interest income earned on the Trust Account, less applicable franchise and income taxes, by the weighted average number of redeemable common stock outstanding for the period. Net loss per common share, basic and diluted, for non-redeemable common stock is calculated by dividing the net loss, less income attributable to redeemable common stock, by the weighted average number of non-redeemable common stock outstanding for the period. Weighted average shares were reduced for the effect of an aggregate of 281,250 shares of common stock that were subject to forfeiture if the over-allotment option was not exercised by the underwriters. Non-redeemable common stock includes the Founder Shares as these shares do not have any redemption features and do not participate in the income earned on the Trust Account.</font> </p> <p style="margin:0pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The following table reflects the calculation of basic and diluted net loss per common share (in dollars, except per share amounts):</font> </p> <p style="margin:0pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;"> <font style="display:inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-size:8pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:10.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">For&nbsp;the&nbsp;Period&nbsp;</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-size:8pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:10.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">from</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-size:8pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:10.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December&nbsp;18,</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-size:8pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:10.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2019</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-size:8pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:10.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Three&nbsp;Months&nbsp;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Six&nbsp;Months&nbsp;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:10.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">(inception)&nbsp;</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-size:8pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:10.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Ended</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Ended</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:10.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Through</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-size:8pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:10.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December&nbsp;31,&nbsp;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December&nbsp;31,&nbsp;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:10.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December&nbsp;31,&nbsp;</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-size:8pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:10.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2020</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2020</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:10.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2019</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Redeemable Common Stock</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Numerator: Earnings allocable to Redeemable Common Stock</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Interest Income</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 4,841</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 4,841</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Income and Franchise Tax</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (4,841)</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (4,841)</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 24pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Net Earnings</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Denominator: Weighted Average Redeemable Common Stock</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Redeemable Common Stock, Basic and Diluted</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 8,009,041</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 8,009,041</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Earnings/Basic and Diluted Redeemable Common Stock</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Non-Redeemable Common Stock</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Numerator: Net Loss minus Redeemable Net Earnings</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Net Loss</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (80,543)</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (80,623)</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (1,000)</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Redeemable Net Earnings</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 0pt 0pt 24pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Non-Redeemable Net Loss</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (80,543)</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (80,623)</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (1,000)</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Denominator: Weighted Average Non-Redeemable Common Stock</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Non-Redeemable Common Stock, Basic and Diluted</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,875,000</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,875,000</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Loss/Basic and Diluted Non-Redeemable Common Stock</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (0.04)</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (0.04)</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.00 </td> </tr> </table></div> <p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">Note: As of December&nbsp;31, 2020, basic and diluted shares are the same as there are no non-redeemable securities that are dilutive to the Company&#x2019;s stockholders.</font> </p><div /></div> </div> 0.00 <div> <div> <div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:74.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display:inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:74.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-size:8pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December&nbsp;31,&nbsp;</font></p> </td> </tr> <tr> <td valign="bottom" style="width:74.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Description</font></p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;"> &nbsp;&nbsp; </font></p> </td> <td valign="bottom" style="width:09.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Level</font></p> </td> <td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;"> &nbsp;&nbsp; </font></p> </td> <td colspan="2" valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2020</font></p> </td> </tr> <tr> <td valign="bottom" style="width:74.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Assets:</font></p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:74.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Marketable securities held in Trust Account &#x2013;Money Market Fund</font></p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p> </td> <td valign="bottom" style="width:09.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;1</font></p> </td> <td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:10.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 80,095,253</font></p> </td> </tr> </table></div> <p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p><div /></div> </div> <div> <div> <p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"> <font style="display:inline;">NOTE&nbsp;8. FAIR VALUE MEASUREMENTS</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The fair value of the Company&#x2019;s financial assets and liabilities reflects management&#x2019;s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:</font> </p> <p style="margin:0pt 0pt 12pt 54pt;text-indent: -36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;">Level&nbsp;1:<font style="display:inline;font-family:Times New Roman,Times,serif;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 12pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;"></font><font style="display:inline;font-family:Times New Roman,Times,serif;">Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.</font> </p> <p style="margin:0pt 0pt 12pt 54pt;text-indent: -36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="text-indent:0pt;margin-left:0pt; padding-right:40.45pt;"><font style="display:inline;font-family:Times New Roman,Times,serif;">Level&nbsp;2:</font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"></font><font style="display:inline;"></font><font style="display:inline;font-family:Times New Roman,Times,serif;">Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.</font></font> </p> <p style="margin:0pt 0pt 12pt 54pt;text-indent: -36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="text-indent:0pt;margin-left:0pt; padding-right:40.45pt;"><font style="display:inline;font-family:Times New Roman,Times,serif;">Level&nbsp;3:</font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"></font><font style="display:inline;"></font><font style="display:inline;font-family:Times New Roman,Times,serif;">Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.</font></font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">At December&nbsp;31, 2020, assets held in the Trust Account were comprised of $80,095,253 in money market funds which are invested in U.S. Treasury Securities. During the six&nbsp;months ended December&nbsp;31, 2020, the Company did not withdraw any interest income from the Trust Account.</font> </p> <p style="margin:0pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The following table presents information about the Company&#x2019;s assets that are measured at fair value on a recurring basis at December&nbsp;31, 2020 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:</font> </p> <p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:74.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"> <font style="display:inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:74.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-size:8pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December&nbsp;31,&nbsp;</font></p> </td> </tr> <tr> <td valign="bottom" style="width:74.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Description</font></p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;"> &nbsp;&nbsp; </font></p> </td> <td valign="bottom" style="width:09.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Level</font></p> </td> <td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;"> &nbsp;&nbsp; </font></p> </td> <td colspan="2" valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2020</font></p> </td> </tr> <tr> <td valign="bottom" style="width:74.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Assets:</font></p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:10.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:74.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Marketable securities held in Trust Account &#x2013;Money Market Fund</font></p> </td> <td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p> </td> <td valign="bottom" style="width:09.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;1</font></p> </td> <td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:10.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 80,095,253</font></p> </td> </tr> </table></div> <p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 1pt;"> <font style="display:inline;font-size:1pt;">&nbsp;</font> </p><div /></div> </div> <div> <div> <p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"> <font style="display:inline;">Fair Value of Financial Instruments</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The fair value of the Company&#x2019;s assets and liabilities, which qualify as financial instruments under ASC Topic 820, &#x201C;Fair Value Measurement,&#x201D; approximates the carrying amounts represented in the accompanying unaudited condensed balance sheets, primarily due to their short-term nature.</font> </p><div /></div> </div> 0 <div> <div> <p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"> <font style="display:inline;">Income Taxes</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The Company complies with the accounting and reporting requirements of ASC Topic 740 &#x201C;Income Taxes,&#x201D; which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. As of December&nbsp;31, 2020, the Company had a deferred tax asset of approximately $17,000, which had a full valuation allowance recorded against it of approximately $17,000.</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The Company&#x2019;s currently taxable income primarily consists of interest income on the Trust Account. The Company&#x2019;s general and administrative costs are generally considered start-up costs and are not currently deductible. During the three and six&nbsp;months ended December&nbsp;31, 2020 the Company recorded no income tax expense. The Company&#x2019;s effective tax rate for the three and six&nbsp;months ended December&nbsp;31, 2020 was zero, which differs from the expected income tax rate due to the start-up costs which are not currently deductible.</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December&nbsp;31, 2020 and June&nbsp;30, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The Company may be subject to potential examination by federal, state and city taxing authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal, state and city tax laws. The Company&#x2019;s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve&nbsp;months. The Company is subject to income tax examinations by major taxing authorities since inception.</font> </p><div /></div> </div> 1000 20787 0 149919 0 4841 4841 4841 4841 4841 80095253 29000 21787 53000 81028885 0 81063721 0 -80090412 0 -214596 -1000 -1000 -1000 -1000 -80 -80 -80623 -80623 -80543 -80543 -80543 -80543 <div> <div> <p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"> <font style="display:inline;">Recent Accounting Pronouncements</font> </p> <p style="margin:0pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company&#x2019;s &nbsp;unaudited condensed financial statements.</font> </p><div /></div> </div> 2803164 -1000 -85464 -85384 <div> <div> <p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"> <font style="display:inline;">NOTE&nbsp;1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">LifeSci Acquisition II Corp. (the &#x201C;Company&#x201D;) was incorporated in Delaware on December&nbsp;18, 2019. The Company was formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business transaction with one or more businesses or entities that the Company has not yet identified (a &#x201C;Business Combination&#x201D;).</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">Although the Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination, the Company intends to focus on businesses operating in North America in the healthcare industry. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">As of December&nbsp;31, 2020, the Company had not commenced any operations. All activity through December&nbsp;31, 2020 relates to the Company&#x2019;s formation and the initial public offering (&#x201C;Initial Public Offering&#x201D;), which is described below, and identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering.</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The registration statement for the Company&#x2019;s Initial Public Offering was declared effective on November&nbsp;20, 2020. On November&nbsp;24, 2020 the Company consummated the Initial Public Offering of 8,009,041 shares of common stock (the &#x201C;Public Shares&#x201D;), which includes the partial exercise by the underwriter of its over-allotment option in the amount of 509,041 Public Shares, at $10.00 per Public Share, generating gross proceeds of $80,090,410 which is described in Note&nbsp;3.</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 3,146,454 warrants (the &#x201C;Private Warrants&#x201D;) at a price of $0.90 per Private Warrant in a private placement to LifeSci Holdings, LLC (the &#x201C;Sponsor&#x201D;), an entity affiliated LifeSci Capital LLC, generating gross proceeds of $2,831,809, which is described in Note&nbsp;4.</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">Transaction costs amounted to $1,858,498, consisting of $1,601,808 in cash underwriting fees and $256,690 of other offering costs.</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">Following the closing of the Initial Public Offering on November&nbsp;24, 2020, an amount of $80,090,410 &nbsp;($10.00 per Public Share) from the net proceeds of the sale of the Public Shares in the Initial Public Offering and the sale of the Private Warrants was placed in a trust account (the &#x201C;Trust Account&#x201D;), and invested in U.S. government securities, within the meaning set forth in Section&nbsp;2(a)(16) of the Investment Company Act of 1940, as amended, or the Investment Company Act, with a maturity of 183&nbsp;days or less or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule&nbsp;2a&#8209;7 of the Investment Company Act, as determined by the Company, until the earlier of: (i)&nbsp;the consummation of a Business Combination or (ii)&nbsp;the distribution of the funds in the Trust Account as described below.</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The Company&#x2019;s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Warrants, although substantially all of the net proceeds are intended to be applied toward consummating a Business Combination. The Company&#x2019;s initial Business Combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the balance in the Trust Account (net of amounts previously released to the Company to pay its tax obligations and for working capital purposes, subject to an annual limit of $250,000) at the time of the signing an agreement to enter into a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully effect a Business Combination.</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The Company will provide its stockholders with the opportunity to redeem all or a portion of their Public Shares sold in the Initial Public Offering upon the completion of a Business Combination either (i)&nbsp;in connection with a stockholder meeting called to approve the Business Combination or (ii)&nbsp;by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then on deposit in the Trust Account (initially $10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations or for working capital purposes).</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the outstanding shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation, conduct the redemptions pursuant to the tender offer rules&nbsp;of the Securities and Exchange Commission (&#x201C;SEC&#x201D;), and file tender offer documents with the SEC prior to completing a Business Combination. If, however, a stockholder approval of the transaction is required by law, or the Company decides to obtain stockholder approval for business or other legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules&nbsp;and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Sponsor and other initial stockholders (collectively, the &#x201C;Initial Stockholders&#x201D;) have agreed to (a)&nbsp;vote their Founder Shares (as defined in Note&nbsp;5), and any Public Shares held by them in favor of a Business Combination and (b)&nbsp;not to convert any shares (including Founder Shares) in connection with a stockholder vote to approve a Business Combination or sell any such shares to the Company in a tender offer in connection with a Business Combination. Additionally, each public stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction.</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">Notwithstanding the foregoing, if the Company seeks stockholder approval of a Business Combination and the Company does not conduct redemptions pursuant to the tender offer rules, a stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a &#x201C;group&#x201D; (as defined in Section&nbsp;13(d)(3)&nbsp;of the Securities Exchange Act of 1934, as amended (the &#x201C;Exchange Act&#x201D;)), will be restricted from redeeming their shares with respect to more than an aggregate of 20% of the Public Shares.</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The Company will have until November&nbsp;24, 2022 to consummate a Business Combination (the &#x201C;Combination Period&#x201D;). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i)&nbsp;cease all operations except for the purpose of winding up, (ii)&nbsp;as promptly as reasonably possible but no more than five business&nbsp;days thereafter, redeem 100% of the outstanding Public Shares, at a per share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned (net of taxes payable), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders&#x2019; rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii)&nbsp;as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the Company&#x2019;s board of directors, proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to its obligations to provide for claims of creditors and the requirements of applicable law. The proceeds deposited in the Trust Account could, however, become subject to claims of creditors.</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The Sponsor and Chardan Healthcare Investments LLC have agreed to (i)&nbsp;waive their redemption rights with respect to Founder Shares and any Public Shares they may acquire during or after the Initial Public Offering in connection with the consummation of a Business Combination, (ii)&nbsp;to waive their rights to liquidating distributions from the Trust Account with respect to their Founder Shares if the Company fails to consummate a Business Combination within the Combination Period and (iii)&nbsp;not to propose an amendment to the Company&#x2019;s Amended and Restated Certificate of Incorporation that would affect the substance or timing of the Company&#x2019;s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the public stockholders an opportunity to redeem their Public Shares in conjunction with any such amendment. However, the Sponsor will be entitled to liquidating distributions with respect to any Public Shares acquired if the Company fails to consummate a Business Combination or liquidates within the Combination Period.</font> </p> <p style="margin:0pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below $10.00 per share, except as to any claims by a third party who executed a waiver of any right, title, interest or claim of any kind in or to any monies held in the Trust Account or to any claims under the Company&#x2019;s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the &#x201C;Securities Act&#x201D;). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except the Company&#x2019;s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.</font> </p><div /></div> </div> 0 256690 0.0001 0.0001 0.0001 1000000 1000000 1000000 0 0 0 0 0 0 149919 0 78488602 0 2831809 2831809 2831809 0 175000 -1000 -80623 10000 <div> <div> <p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"> <font style="display:inline;">NOTE&nbsp;5. RELATED PARTY TRANSACTIONS</font> </p> <p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"> <font style="display:inline;">Founder Shares</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">On January&nbsp;1, 2020, the Company issued an aggregate of 2,156,250 shares of common stock (the &#x201C;Founder Shares&#x201D;) to the Sponsor for an aggregate purchase price of $25,000. On September&nbsp;30, 2020, LifeSci Holdings LLC transferred 215,625 Founder Shares to Chardan Healthcare Investments LLC, an investor in the Sponsor. The Founder Shares included an aggregate of up to 153,990 shares of common stock that remained subject to forfeiture by the Sponsor, following the underwriters&#x2019; election to partially exercise their over-allotment option so that the number of Founder Shares would collectively represent 20% of the Company&#x2019;s issued and outstanding shares upon the completion of the Initial Public Offering. On January&nbsp;8, 2021, the underwriters&#x2019; election to exercise their remaining over-allotment option expired unexercised, resulting in 615,959 shares no longer subject to forfeiture and the forfeiture of 153,990 shares. Accordingly, as of January&nbsp;8, 2021, there are 2,002,260 Founder Shares issued and outstanding (Note&nbsp;9).</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The Sponsor and Chardan Healthcare Investments LLC have agreed that, subject to certain limited exceptions, 50% of the Founder Shares will not be transferred, assigned, sold or released from escrow until the earlier of (i)&nbsp;six&nbsp;months after the date of the consummation of a Business Combination or (ii)&nbsp;the date on which the closing price of the Company&#x2019;s shares of common stock equals or exceeds $12.50 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations) for any 20 trading&nbsp;days within any 30&#8209;trading day period commencing after a Business Combination and the remaining 50% of the Founder Shares will not be transferred, assigned, sold or released from escrow until six&nbsp;months after the date of the consummation of a Business Combination, or earlier, in either case, if, subsequent to a Business Combination, the Company consummates a subsequent liquidation, merger, stock exchange or other similar transaction which results in all of the stockholders having the right to exchange their shares of common stock for cash, securities or other property.</font> </p> <p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"> <font style="display:inline;">Administrative Support Agreement</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The Company entered into an agreement, commencing on November&nbsp;20, 2020 through the earlier of the Company&#x2019;s consummation of a Business Combination and its liquidation, to pay an affiliate of the Sponsor a total of $10,000 per&nbsp;month for office space, utilities and secretarial support. For each of the three and six&nbsp;months ended December&nbsp;31, 2020, the Company incurred $10,000 in fees for these services, of which such amount is included in accrued expenses in the accompanying unaudited condensed balance sheets.</font> </p> <p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"> <font style="display:inline;">Promissory Note&nbsp;&#x2014; Related Party</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">On June&nbsp;19, 2020, the Company issued an unsecured promissory note to the Sponsor (the &#x201C;Promissory Note&#x201D;), pursuant to which the Company could borrow up to an aggregate principal amount of $175,000. The Promissory Note&nbsp;was non-interest bearing and payable within 15&nbsp;days of the Sponsor providing the Company with written notice of demand. The outstanding balance under the Promissory Note&nbsp;of $175,000 was repaid at the closing of the Initial Public Offering on November&nbsp;24, 2020.</font> </p> <p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"> <font style="display:inline;">Related Party Loans</font> </p> <p style="margin:0pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">In order to finance transaction costs in connection with a Business Combination, the Sponsor, an affiliate of the Sponsor, or the Company&#x2019;s officers and directors may, but are not obligated to, loan the Company funds from time to time or at any time, as may be required (&#x201C;Working Capital Loans&#x201D;). Each Working Capital Loan would be evidenced by a promissory note. The Working Capital Loans would be paid upon consummation of a Business Combination, without interest or, at the lender&#x2019;s discretion, up to $500,000 of such Working Capital Loans may be converted into warrants of the post Business Combination entity at a price of $0.90 per warrant. In the event that a Business Combination does not close, the Company may use a portion of the proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The warrants would be identical to the Private Warrants. As of December&nbsp;31, 2020 and June 30, 2020, the Company had no outstanding borrowings under the Working Capital Loans.</font> </p><div /></div> </div> 0 175000 175000 -1000 -81623 <div> <div> <p style="margin:0pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The following table reflects the calculation of basic and diluted net loss per common share (in dollars, except per share amounts):</font> </p> <p style="margin:0pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;"> <font style="display:inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-size:8pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:10.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">For&nbsp;the&nbsp;Period&nbsp;</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-size:8pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:10.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">from</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-size:8pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:10.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December&nbsp;18,</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-size:8pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:10.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2019</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-size:8pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:10.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Three&nbsp;Months&nbsp;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Six&nbsp;Months&nbsp;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:10.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">(inception)&nbsp;</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-size:8pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:10.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Ended</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Ended</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:10.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Through</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-size:8pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:10.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December&nbsp;31,&nbsp;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December&nbsp;31,&nbsp;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:10.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December&nbsp;31,&nbsp;</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-size:8pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:10.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2020</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2020</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:10.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2019</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Redeemable Common Stock</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Numerator: Earnings allocable to Redeemable Common Stock</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Interest Income</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 4,841</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 4,841</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Income and Franchise Tax</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (4,841)</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (4,841)</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 24pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Net Earnings</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Denominator: Weighted Average Redeemable Common Stock</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Redeemable Common Stock, Basic and Diluted</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 8,009,041</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 8,009,041</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Earnings/Basic and Diluted Redeemable Common Stock</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Non-Redeemable Common Stock</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Numerator: Net Loss minus Redeemable Net Earnings</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Net Loss</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (80,543)</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (80,623)</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (1,000)</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Redeemable Net Earnings</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 0pt 0pt 24pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Non-Redeemable Net Loss</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (80,543)</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (80,623)</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (1,000)</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Denominator: Weighted Average Non-Redeemable Common Stock</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Non-Redeemable Common Stock, Basic and Diluted</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,875,000</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,875,000</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Loss/Basic and Diluted Non-Redeemable Common Stock</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (0.04)</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (0.04)</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.00 </td> </tr> </table></div> <p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p><div /></div> </div> 10.00 10.00 10.00 2156250 2156250 2564582 <div> <div> <p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"> <font style="display:inline;">NOTE&nbsp;2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</font> </p> <p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"> <font style="display:inline;">Basis of Presentation</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201C;GAAP&#x201D;) for interim financial information and in accordance with the instructions to Form&nbsp;10&#8209;Q and Article&nbsp;8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules&nbsp;and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The accompanying unaudited condensed financial statements should be read in conjunction with the Company&#x2019;s prospectus for its Initial Public Offering as filed with the SEC on November&nbsp;23, 2020, as well as the Company&#x2019;s Current Reports on Form&nbsp;8&#8209;K, as filed with the SEC on November&nbsp;25, 2020, and December&nbsp;1, 2020. The interim results for the three and six&nbsp;months ended December&nbsp;31, 2020 are not necessarily indicative of the results to be expected for the&nbsp;year ending June&nbsp;30, 2021 or for any future interim periods.</font> </p> <p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"> <font style="display:inline;">Emerging Growth Company</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The Company is an &#x201C;emerging growth company,&#x201D; as defined in Section&nbsp;2(a)&nbsp;of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the &#x201C;JOBS Act&#x201D;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section&nbsp;404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">Further, Section&nbsp;102(b)(1)&nbsp;of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#x2019;s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</font> </p> <p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"> <font style="display:inline;">Use of Estimates</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The preparation of the unaudited condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods.</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</font> </p> <p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"> <font style="display:inline;">Cash and Cash Equivalents</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The Company considers all short-term investments with an original maturity of three&nbsp;months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of December&nbsp;31, 2020 and June&nbsp;30, 2020.</font> </p> <p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"> <font style="display:inline;">Common Stock Subject to Possible Redemption</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The Company accounts for its common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (&#x201C;ASC&#x201D;) Topic 480 &#x201C;Distinguishing Liabilities from Equity.&#x201D; Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&#x2019;s control) is classified as temporary equity. At all other times, common stock is classified as stockholders&#x2019; equity. The Company&#x2019;s common stock features certain redemption rights that are considered to be outside of the Company&#x2019;s control and subject to occurrence of uncertain future events. Accordingly, at December&nbsp;31, 2020, common stock subject to possible redemption are presented as temporary equity, outside of the stockholders&#x2019; equity section of the Company&#x2019;s &nbsp;unaudited condensed balance sheet.</font> </p> <p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"> <font style="display:inline;">Offering Costs</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">Offering costs consist of legal, accounting, underwriting fees and other costs incurred through the balance sheet date that are directly related to the Initial Public Offering. Offering costs amounting to $1,858,498 were charged to stockholders&#x2019; equity upon the completion of the Initial Public Offering.</font> </p> <p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"> <font style="display:inline;">Income Taxes</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The Company complies with the accounting and reporting requirements of ASC Topic 740 &#x201C;Income Taxes,&#x201D; which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. As of December&nbsp;31, 2020, the Company had a deferred tax asset of approximately $17,000, which had a full valuation allowance recorded against it of approximately $17,000.</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The Company&#x2019;s currently taxable income primarily consists of interest income on the Trust Account. The Company&#x2019;s general and administrative costs are generally considered start-up costs and are not currently deductible. During the three and six&nbsp;months ended December&nbsp;31, 2020 the Company recorded no income tax expense. The Company&#x2019;s effective tax rate for the three and six&nbsp;months ended December&nbsp;31, 2020 was zero, which differs from the expected income tax rate due to the start-up costs which are not currently deductible.</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December&nbsp;31, 2020 and June&nbsp;30, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The Company may be subject to potential examination by federal, state and city taxing authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal, state and city tax laws. The Company&#x2019;s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve&nbsp;months. The Company is subject to income tax examinations by major taxing authorities since inception.</font> </p> <p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"> <font style="display:inline;">Net Loss Per Common Share</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">Net loss per common share is computed by dividing net loss by the weighted average number of common shares outstanding for the period. The Company has not considered the effect of warrants sold in connection with the private placement to purchase 3,146,454 shares of common stock in the calculation of diluted loss per common share, since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive under the treasury stock method.</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The Company&#x2019;s &nbsp;unaudited condensed statements of operations includes a presentation of loss per share for common shares subject to possible redemption in a manner similar to the two-class method of loss per share. Net income per common share, basic and diluted, for redeemable common stock is calculated by dividing the interest income earned on the Trust Account, less applicable franchise and income taxes, by the weighted average number of redeemable common stock outstanding for the period. Net loss per common share, basic and diluted, for non-redeemable common stock is calculated by dividing the net loss, less income attributable to redeemable common stock, by the weighted average number of non-redeemable common stock outstanding for the period. Weighted average shares were reduced for the effect of an aggregate of 281,250 shares of common stock that were subject to forfeiture if the over-allotment option was not exercised by the underwriters. Non-redeemable common stock includes the Founder Shares as these shares do not have any redemption features and do not participate in the income earned on the Trust Account.</font> </p> <p style="margin:0pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The following table reflects the calculation of basic and diluted net loss per common share (in dollars, except per share amounts):</font> </p> <p style="margin:0pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;"> <font style="display:inline;font-size:1pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-size:8pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:10.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">For&nbsp;the&nbsp;Period&nbsp;</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-size:8pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:10.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">from</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-size:8pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:10.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December&nbsp;18,</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-size:8pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:10.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2019</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-size:8pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:10.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Three&nbsp;Months&nbsp;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Six&nbsp;Months&nbsp;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:10.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">(inception)&nbsp;</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-size:8pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:10.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Ended</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Ended</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:10.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Through</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-size:8pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:10.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December&nbsp;31,&nbsp;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December&nbsp;31,&nbsp;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:10.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December&nbsp;31,&nbsp;</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-size:8pt;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:10.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2020</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2020</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p> </td> <td colspan="2" valign="bottom" style="width:10.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2019</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Redeemable Common Stock</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Numerator: Earnings allocable to Redeemable Common Stock</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Interest Income</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 4,841</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 4,841</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Income and Franchise Tax</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (4,841)</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (4,841)</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 24pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Net Earnings</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Denominator: Weighted Average Redeemable Common Stock</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Redeemable Common Stock, Basic and Diluted</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 8,009,041</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 8,009,041</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Earnings/Basic and Diluted Redeemable Common Stock</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Non-Redeemable Common Stock</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Numerator: Net Loss minus Redeemable Net Earnings</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Net Loss</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (80,543)</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (80,623)</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (1,000)</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Redeemable Net Earnings</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 0pt 0pt 24pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Non-Redeemable Net Loss</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (80,543)</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (80,623)</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (1,000)</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Denominator: Weighted Average Non-Redeemable Common Stock</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Non-Redeemable Common Stock, Basic and Diluted</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,875,000</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,875,000</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p> </td> </tr> <tr> <td valign="bottom" style="width:62.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Loss/Basic and Diluted Non-Redeemable Common Stock</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:09.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (0.04)</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (0.04)</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.00 </td> </tr> </table></div> <p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">Note: As of December&nbsp;31, 2020, basic and diluted shares are the same as there are no non-redeemable securities that are dilutive to the Company&#x2019;s stockholders.</font> </p> <p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"> <font style="display:inline;">Concentration of Credit Risk</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</font> </p> <p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"> <font style="display:inline;">Fair Value of Financial Instruments</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The fair value of the Company&#x2019;s assets and liabilities, which qualify as financial instruments under ASC Topic 820, &#x201C;Fair Value Measurement,&#x201D; approximates the carrying amounts represented in the accompanying unaudited condensed balance sheets, primarily due to their short-term nature.</font> </p> <p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"> <font style="display:inline;">Recent Accounting Pronouncements</font> </p> <p style="margin:0pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company&#x2019;s &nbsp;unaudited condensed financial statements.</font> </p> <p style="margin:0pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 1pt;"> <font style="display:inline;font-size:1pt;">&nbsp;</font> </p><div /></div> </div> -1000 -1000 24000 24000 24784 216 -1000 23920 24784 216 -1080 5000008 5000008 5081375 256 -81623 <div> <div> <p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"> <font style="display:inline;">NOTE&nbsp;7. STOCKHOLDERS&#x2019; EQUITY</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-weight:bold;font-style:italic;">Preferred Stock</font><font style="display:inline;">&nbsp;&#x2014; The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company&#x2019;s board of directors. At December&nbsp;31, 2020, there were no shares of preferred stock issued or outstanding.</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-weight:bold;font-style:italic;">Common Stock</font><font style="display:inline;">&nbsp;&#x2014; The Company is authorized to issue 30,000,000 shares of common stock with a par value of $0.0001 per share. Holders of the Company&#x2019;s common stock are entitled to one vote for each share. At December&nbsp;31, 2020, there were 2,564,582 shares of common stock issued and outstanding, excluding 7,600,709 shares of common stock subject to possible redemption.</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-weight:bold;font-style:italic;">Warrants</font><font style="display:inline;">&nbsp;&#x2014;The Private Warrants will become exercisable at any time commencing on the later of (1)&nbsp;one&nbsp;year after the closing of the Initial Public Offering or (2)&nbsp;the consummation of a Business Combination; provided that the Company has an effective and current registration statement covering the shares of common stock issuable upon the exercise of the Public Warrants and a current prospectus relating to such shares of common stock.</font> </p> <p style="margin:0pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The Private Warrants purchased by the Sponsor will be exercisable on a cashless basis and not be exercisable more than five&nbsp;years from the commencement of sales of the Initial Public Offering, in accordance with FINRA Rule&nbsp;5110(g)(8)(A), as long as the Sponsor or any of its related persons beneficially own these Private Warrants.</font> </p><div /></div> </div> 2156250 8009041 8009041 25000 215625 78231912 78231111 801 <div> <div> <p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"> <font style="display:inline;">NOTE&nbsp;9. SUBSEQUENT EVENTS</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the unaudited condensed financial statements were issued. Based upon this review, other than as described below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements.</font> </p> <p style="margin:0pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">On January&nbsp;8, 2021, the underwriters&#x2019; election to exercise their remaining over-allotment option expired unexercised, resulting in the forfeiture of 153,990&nbsp;Founder Shares. Accordingly, as of January&nbsp;8, 2021, there are 2,002,260 Founder Shares issued and outstanding.</font> </p><div /></div> </div> 76007090 10.00 7600709 7600709 0 0 <div> <div> <p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"> <font style="display:inline;">Use of Estimates</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The preparation of the unaudited condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods.</font> </p> <p style="margin:0pt 0pt 12pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</font> </p><div /></div> </div> P5Y 1875000 1875000 8009041 8009041 1875000 1875000 8009041 8009041 EX-101.SCH 7 lsaq-20201231.xsd XBRL TAXONOMY EXTENSION SCHEMA 00100 - Statement - CONDENSED BALANCE SHEET link:presentationLink link:calculationLink link:definitionLink 00200 - Statement - CONDENSED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 00400 - Statement - CONDENSED STATEMENT OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 40202 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Net Income (Loss) Per Common Share (Details) link:presentationLink link:calculationLink link:definitionLink 00090 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00105 - Statement - CONDENSED BALANCE SHEET (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00300 - Statement - CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 00305 - Statement - CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 10401 - Disclosure - PRIVATE PLACEMENT link:presentationLink link:calculationLink link:definitionLink 10501 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 40101 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 40201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Class A Common Stock Subject to Possible Redemption (Details) link:presentationLink link:calculationLink link:definitionLink 40301 - Disclosure - PUBLIC OFFERING (Details) link:presentationLink link:calculationLink link:definitionLink 40401 - Disclosure - PRIVATE PLACEMENT (Details) link:presentationLink link:calculationLink link:definitionLink 40501 - Disclosure - RELATED PARTY TRANSACTIONS - Founder Shares (Details) link:presentationLink link:calculationLink link:definitionLink 40502 - Disclosure - RELATED PARTY TRANSACTIONS - Additional information (Details) link:presentationLink link:calculationLink link:definitionLink 40602 - Disclosure - COMMITMENTS - Underwriting Agreement (Details) link:presentationLink link:calculationLink link:definitionLink 40603 - Disclosure - COMMITMENTS - Business combination marketing agreement (Details) link:presentationLink link:calculationLink link:definitionLink 40702 - Disclosure - STOCKHOLDERS' EQUITY - Common Stock Shares (Details) link:presentationLink link:calculationLink link:definitionLink 40703 - Disclosure - STOCKHOLDERS' EQUITY - Warrants (Details) link:presentationLink link:calculationLink link:definitionLink 40801 - Disclosure - FAIR VALUE MEASUREMENTS - Gross holding gains and fair value of held-to-maturity securities (Details) link:presentationLink link:calculationLink link:definitionLink 40901 - Disclosure - SUBSEQUENT EVENTS (Details) link:presentationLink link:calculationLink link:definitionLink 10101 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS link:presentationLink link:calculationLink link:definitionLink 10201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 10301 - Disclosure - PUBLIC OFFERING link:presentationLink link:calculationLink link:definitionLink 10601 - Disclosure - COMMITMENTS link:presentationLink link:calculationLink link:definitionLink 10701 - Disclosure - STOCKHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 10801 - Disclosure - FAIR VALUE MEASUREMENTS link:presentationLink link:calculationLink link:definitionLink 10901 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 20202 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 30203 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 30803 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 40203 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) link:presentationLink link:calculationLink link:definitionLink 40601 - Disclosure - COMMITMENTS - Registration and Stockholder Rights (Details) link:presentationLink link:calculationLink link:definitionLink 40701 - Disclosure - STOCKHOLDERS' EQUITY - Preferred Stock Shares (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 lsaq-20201231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 9 lsaq-20201231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 10 lsaq-20201231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 11 lsaq-20201231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 12 R1.htm IDEA: XBRL DOCUMENT v3.20.4
Document and Entity Information - shares
6 Months Ended
Dec. 31, 2020
Jan. 29, 2021
Document and Entity Information    
Document Type 10-Q  
Document Period End Date Dec. 31, 2020  
Entity Registrant Name Lifesci Acquisition II Corp.  
Entity Current Reporting Status Yes  
Transition Report true  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Entity Shell Company true  
Entity Common Stock, Shares Outstanding   10,011,301
Entity Central Index Key 0001819113  
Current Fiscal Year End Date --06-30  
Document Fiscal Year Focus 2021  
Document Fiscal Period Focus Q2  
Amendment Flag false  
Trading Symbol LSAQ  
Title of 12(b) Security Shares of Common Stock, $0.0001 par value  
Security Exchange Name NASDAQ  
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.20.4
CONDENSED BALANCE SHEET - USD ($)
Dec. 31, 2020
Jun. 30, 2020
Current assets    
Cash $ 783,713 $ 25,000
Prepaid expenses 149,919  
Total Current Assets 933,632 25,000
Deferred offering costs   28,000
Cash and marketable securities held in Trust Account 80,095,253  
Total Assets 81,028,885 53,000
Current liabilities    
Accrued expenses 21,787 1,000
Accrued offering costs   28,000
Total Liabilities 21,787 29,000
Commitments and Contingencies
Common stock subject to possible redemption, 7,600,709 shares at $10.00 per share 76,007,090  
Stockholders' Equity    
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; no shares issued and outstanding
Common stock, $0.0001 par value; 30,000,000 shares authorized; 2,564,582 and 2,156,250 shares issued and outstanding (excluding 7,600,709 and no shares subject to possible redemption) at December 31, 2020 and June 30, 2020, respectively 256 216
Additional paid-in capital 5,081,375 24,784
Accumulated deficit (81,623) (1,000)
Total Stockholders' Equity 5,000,008 24,000
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 81,028,885 $ 53,000
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.20.4
CONDENSED BALANCE SHEET (Parenthetical)
Dec. 31, 2020
$ / shares
shares
Shares subject to possible redemption 7,600,709
Preferred stock, par value | $ / shares $ 0.0001
Preferred stock, shares authorized 1,000,000
Preferred stock, shares issued 0
Preferred stock, shares outstanding 0
Common stock, par value | $ / shares $ 0.0001
Common stock, shares authorized 30,000,000
Common stock, shares issued 2,564,582
Common stock, shares outstanding 2,564,582
Over-allotment  
Common stock, shares authorized 1,125,000
Class A common stock  
Shares subject to possible redemption 7,600,709
Shares subject to possible redemption, par value per share | $ / shares $ 10.00
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.20.4
CONDENSED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended 6 Months Ended
Dec. 31, 2019
Dec. 31, 2020
Dec. 31, 2020
Formation and operating costs $ 1,000 $ 85,384 $ 85,464
Loss from operations (1,000) (85,384) (85,464)
Other income:      
Interest earned on marketable securities held in Trust Account 0 4,841 4,841
Net loss $ (1,000) (80,543) (80,623)
Redeemable common stock      
Other income:      
Interest earned on marketable securities held in Trust Account   $ 4,841 $ 4,841
Weighted average shares outstanding of common stock   8,009,041 8,009,041
Basic and diluted net loss per common share $ 0.00 $ 0.00 $ 0.00
Non-redeemable common stock      
Other income:      
Net loss $ (1,000) $ (80,543) $ (80,623)
Weighted average shares outstanding of common stock   1,875,000 1,875,000
Basic and diluted net loss per common share $ 0.00 $ (0.04) $ (0.04)
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.20.4
CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at the beginning at Jun. 30, 2020 $ 216 $ 24,784 $ (1,000) $ 24,000
Balance at the beginning (in shares) at Jun. 30, 2020 2,156,250      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss     (80) (80)
Balance at the end at Sep. 30, 2020 $ 216 24,784 (1,080) 23,920
Balance at the end (in shares) at Sep. 30, 2020 2,156,250      
Balance at the beginning at Jun. 30, 2020 $ 216 24,784 (1,000) 24,000
Balance at the beginning (in shares) at Jun. 30, 2020 2,156,250      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss       (80,623)
Balance at the end at Dec. 31, 2020 $ 256 5,081,375 (81,623) 5,000,008
Balance at the end (in shares) at Dec. 31, 2020 2,564,582      
Balance at the beginning at Sep. 30, 2020 $ 216 24,784 (1,080) 23,920
Balance at the beginning (in shares) at Sep. 30, 2020 2,156,250      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Sale of 8,009,041 Public Shares, net of underwriting discounts and offering costs $ 801 78,231,111   $ 78,231,912
Sale of 8,009,041 Public Shares, net of underwriting discounts and offering costs (in shares) 8,009,041     8,009,041
Sale of 3,146,454 Private Warrants   2,831,809   $ 2,831,809
Common stock subject to possible redemption $ (761) (76,006,329)   (76,007,090)
Common stock subject to possible redemption (in shares) (7,600,709)      
Net loss     (80,543) (80,543)
Balance at the end at Dec. 31, 2020 $ 256 $ 5,081,375 $ (81,623) $ 5,000,008
Balance at the end (in shares) at Dec. 31, 2020 2,564,582      
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.20.4
CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Parenthetical)
3 Months Ended
Dec. 31, 2020
shares
CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY  
Sale of Public Shares (in shares) 8,009,041
Sale of warrants (in shares) 3,146,454
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.20.4
CONDENSED STATEMENT OF CASH FLOWS - USD ($)
6 Months Ended
Dec. 31, 2019
Dec. 31, 2020
Cash Flows from Operating Activities:    
Net loss $ (1,000) $ (80,623)
Adjustments to reconcile net loss to net cash used in operating activities:    
Interest earned on marketable securities held in Trust Account 0 (4,841)
Changes in operating assets and liabilities:    
Prepaid expenses 0 (149,919)
Accrued expenses 1,000 20,787
Net cash used in operating activities 0 (214,596)
Cash Flows from Investing Activities:    
Investment of cash in Trust Account 0 (80,090,412)
Net cash used in investing activities 0 (80,090,412)
Cash Flows from Financing Activities:    
Proceeds from sale of Public Shares, net of underwriting discounts paid 0 78,488,602
Proceeds from sale of Private Warrants 0 2,831,809
Proceeds from promissory note - related party 0 175,000
Repayment of promissory note - related party 0 (175,000)
Payments of offering costs 0 (256,690)
Net cash provided by financing activities 0 81,063,721
Net Change in Cash 0 758,713
Cash - Beginning 0 25,000
Cash - Ending 0 783,713
Non-Cash Investing and Financing Activities:    
Initial classification of common stock subject to possible redemption 0 76,087,640
Change in value of common stock subject to possible redemption 0 (80,550)
Offering costs included in accrued offering costs $ 0 $ 151,430
XML 19 R8.htm IDEA: XBRL DOCUMENT v3.20.4
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
6 Months Ended
Dec. 31, 2020
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS  
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS

NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS

LifeSci Acquisition II Corp. (the “Company”) was incorporated in Delaware on December 18, 2019. The Company was formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business transaction with one or more businesses or entities that the Company has not yet identified (a “Business Combination”).

Although the Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination, the Company intends to focus on businesses operating in North America in the healthcare industry. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.

As of December 31, 2020, the Company had not commenced any operations. All activity through December 31, 2020 relates to the Company’s formation and the initial public offering (“Initial Public Offering”), which is described below, and identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering.

The registration statement for the Company’s Initial Public Offering was declared effective on November 20, 2020. On November 24, 2020 the Company consummated the Initial Public Offering of 8,009,041 shares of common stock (the “Public Shares”), which includes the partial exercise by the underwriter of its over-allotment option in the amount of 509,041 Public Shares, at $10.00 per Public Share, generating gross proceeds of $80,090,410 which is described in Note 3.

Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 3,146,454 warrants (the “Private Warrants”) at a price of $0.90 per Private Warrant in a private placement to LifeSci Holdings, LLC (the “Sponsor”), an entity affiliated LifeSci Capital LLC, generating gross proceeds of $2,831,809, which is described in Note 4.

Transaction costs amounted to $1,858,498, consisting of $1,601,808 in cash underwriting fees and $256,690 of other offering costs.

Following the closing of the Initial Public Offering on November 24, 2020, an amount of $80,090,410  ($10.00 per Public Share) from the net proceeds of the sale of the Public Shares in the Initial Public Offering and the sale of the Private Warrants was placed in a trust account (the “Trust Account”), and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended, or the Investment Company Act, with a maturity of 183 days or less or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule 2a‑7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the consummation of a Business Combination or (ii) the distribution of the funds in the Trust Account as described below.

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Warrants, although substantially all of the net proceeds are intended to be applied toward consummating a Business Combination. The Company’s initial Business Combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the balance in the Trust Account (net of amounts previously released to the Company to pay its tax obligations and for working capital purposes, subject to an annual limit of $250,000) at the time of the signing an agreement to enter into a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully effect a Business Combination.

The Company will provide its stockholders with the opportunity to redeem all or a portion of their Public Shares sold in the Initial Public Offering upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then on deposit in the Trust Account (initially $10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations or for working capital purposes).

The Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the outstanding shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation, conduct the redemptions pursuant to the tender offer rules of the Securities and Exchange Commission (“SEC”), and file tender offer documents with the SEC prior to completing a Business Combination. If, however, a stockholder approval of the transaction is required by law, or the Company decides to obtain stockholder approval for business or other legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Sponsor and other initial stockholders (collectively, the “Initial Stockholders”) have agreed to (a) vote their Founder Shares (as defined in Note 5), and any Public Shares held by them in favor of a Business Combination and (b) not to convert any shares (including Founder Shares) in connection with a stockholder vote to approve a Business Combination or sell any such shares to the Company in a tender offer in connection with a Business Combination. Additionally, each public stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction.

Notwithstanding the foregoing, if the Company seeks stockholder approval of a Business Combination and the Company does not conduct redemptions pursuant to the tender offer rules, a stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined in Section 13(d)(3) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming their shares with respect to more than an aggregate of 20% of the Public Shares.

The Company will have until November 24, 2022 to consummate a Business Combination (the “Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than five business days thereafter, redeem 100% of the outstanding Public Shares, at a per share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned (net of taxes payable), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the Company’s board of directors, proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to its obligations to provide for claims of creditors and the requirements of applicable law. The proceeds deposited in the Trust Account could, however, become subject to claims of creditors.

The Sponsor and Chardan Healthcare Investments LLC have agreed to (i) waive their redemption rights with respect to Founder Shares and any Public Shares they may acquire during or after the Initial Public Offering in connection with the consummation of a Business Combination, (ii) to waive their rights to liquidating distributions from the Trust Account with respect to their Founder Shares if the Company fails to consummate a Business Combination within the Combination Period and (iii) not to propose an amendment to the Company’s Amended and Restated Certificate of Incorporation that would affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the public stockholders an opportunity to redeem their Public Shares in conjunction with any such amendment. However, the Sponsor will be entitled to liquidating distributions with respect to any Public Shares acquired if the Company fails to consummate a Business Combination or liquidates within the Combination Period.

In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below $10.00 per share, except as to any claims by a third party who executed a waiver of any right, title, interest or claim of any kind in or to any monies held in the Trust Account or to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

XML 20 R9.htm IDEA: XBRL DOCUMENT v3.20.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
6 Months Ended
Dec. 31, 2020
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10‑Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s prospectus for its Initial Public Offering as filed with the SEC on November 23, 2020, as well as the Company’s Current Reports on Form 8‑K, as filed with the SEC on November 25, 2020, and December 1, 2020. The interim results for the three and six months ended December 31, 2020 are not necessarily indicative of the results to be expected for the year ending June 30, 2021 or for any future interim periods.

Emerging Growth Company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

The preparation of the unaudited condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of December 31, 2020 and June 30, 2020.

Common Stock Subject to Possible Redemption

The Company accounts for its common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at December 31, 2020, common stock subject to possible redemption are presented as temporary equity, outside of the stockholders’ equity section of the Company’s  unaudited condensed balance sheet.

Offering Costs

Offering costs consist of legal, accounting, underwriting fees and other costs incurred through the balance sheet date that are directly related to the Initial Public Offering. Offering costs amounting to $1,858,498 were charged to stockholders’ equity upon the completion of the Initial Public Offering.

Income Taxes

The Company complies with the accounting and reporting requirements of ASC Topic 740 “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. As of December 31, 2020, the Company had a deferred tax asset of approximately $17,000, which had a full valuation allowance recorded against it of approximately $17,000.

The Company’s currently taxable income primarily consists of interest income on the Trust Account. The Company’s general and administrative costs are generally considered start-up costs and are not currently deductible. During the three and six months ended December 31, 2020 the Company recorded no income tax expense. The Company’s effective tax rate for the three and six months ended December 31, 2020 was zero, which differs from the expected income tax rate due to the start-up costs which are not currently deductible.

ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2020 and June 30, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

The Company may be subject to potential examination by federal, state and city taxing authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal, state and city tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. The Company is subject to income tax examinations by major taxing authorities since inception.

Net Loss Per Common Share

Net loss per common share is computed by dividing net loss by the weighted average number of common shares outstanding for the period. The Company has not considered the effect of warrants sold in connection with the private placement to purchase 3,146,454 shares of common stock in the calculation of diluted loss per common share, since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive under the treasury stock method.

The Company’s  unaudited condensed statements of operations includes a presentation of loss per share for common shares subject to possible redemption in a manner similar to the two-class method of loss per share. Net income per common share, basic and diluted, for redeemable common stock is calculated by dividing the interest income earned on the Trust Account, less applicable franchise and income taxes, by the weighted average number of redeemable common stock outstanding for the period. Net loss per common share, basic and diluted, for non-redeemable common stock is calculated by dividing the net loss, less income attributable to redeemable common stock, by the weighted average number of non-redeemable common stock outstanding for the period. Weighted average shares were reduced for the effect of an aggregate of 281,250 shares of common stock that were subject to forfeiture if the over-allotment option was not exercised by the underwriters. Non-redeemable common stock includes the Founder Shares as these shares do not have any redemption features and do not participate in the income earned on the Trust Account.

The following table reflects the calculation of basic and diluted net loss per common share (in dollars, except per share amounts):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the Period 

 

 

 

 

 

 

 

 

from

 

 

 

 

 

 

 

 

December 18,

 

 

 

 

 

 

 

 

2019

 

 

Three Months 

 

Six Months 

 

(inception) 

 

 

Ended

 

Ended

 

Through

 

 

December 31, 

 

December 31, 

 

December 31, 

 

    

2020

    

2020

    

2019

Redeemable Common Stock

 

 

  

 

 

  

 

 

  

Numerator: Earnings allocable to Redeemable Common Stock

 

 

  

 

 

  

 

 

  

Interest Income

 

$

4,841

 

$

4,841

 

$

 —

Income and Franchise Tax

 

 

(4,841)

 

 

(4,841)

 

 

 —

Net Earnings

 

$

 —

 

$

 —

 

$

 —

Denominator: Weighted Average Redeemable Common Stock

 

 

  

 

 

  

 

 

  

Redeemable Common Stock, Basic and Diluted

 

 

8,009,041

 

 

8,009,041

 

 

 —

Earnings/Basic and Diluted Redeemable Common Stock

 

$

 —

 

$

 —

 

$

 —

 

 

 

 

 

 

 

 

 

 

Non-Redeemable Common Stock

 

 

  

 

 

  

 

 

  

Numerator: Net Loss minus Redeemable Net Earnings

 

 

  

 

 

  

 

 

  

Net Loss

 

$

(80,543)

 

$

(80,623)

 

$

(1,000)

Redeemable Net Earnings

 

 

 —

 

 

 —

 

 

 —

Non-Redeemable Net Loss

 

$

(80,543)

 

$

(80,623)

 

$

(1,000)

Denominator: Weighted Average Non-Redeemable Common Stock

 

 

  

 

 

  

 

 

  

Non-Redeemable Common Stock, Basic and Diluted

 

 

1,875,000

 

 

1,875,000

 

 

 —

Loss/Basic and Diluted Non-Redeemable Common Stock

 

$

(0.04)

 

$

(0.04)

 

$

0.00

 

Note: As of December 31, 2020, basic and diluted shares are the same as there are no non-redeemable securities that are dilutive to the Company’s stockholders.

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.

Fair Value of Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying unaudited condensed balance sheets, primarily due to their short-term nature.

Recent Accounting Pronouncements

Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s  unaudited condensed financial statements.

 

XML 21 R10.htm IDEA: XBRL DOCUMENT v3.20.4
PUBLIC OFFERING
6 Months Ended
Dec. 31, 2020
PUBLIC OFFERING  
PUBLIC OFFERING

NOTE 3. PUBLIC OFFERING

Pursuant to the Initial Public Offering, the Company sold 8,009,041 Public Shares, which includes the partial exercise by the underwriters of their over-allotment option in the amount of 509,041 Public Shares, at a purchase price of $10.00 per Public Share.

XML 22 R11.htm IDEA: XBRL DOCUMENT v3.20.4
PRIVATE PLACEMENT
6 Months Ended
Dec. 31, 2020
PRIVATE PLACEMENT  
PRIVATE PLACEMENT

NOTE 4. PRIVATE PLACEMENT

Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 3,146,454 Private Warrants at a price of $0.90 per Private Warrant for an aggregate purchase price of $2,831,809. Each Private Warrant is exercisable to purchase one share of common stock at an exercise price of $11.50 per warrant. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law). There will be no redemption rights or liquidating distributions from the Trust Account with respect to the Private Warrants.

XML 23 R12.htm IDEA: XBRL DOCUMENT v3.20.4
RELATED PARTY TRANSACTIONS
6 Months Ended
Dec. 31, 2020
RELATED PARTY TRANSACTIONS  
RELATED PARTY TRANSACTIONS

NOTE 5. RELATED PARTY TRANSACTIONS

Founder Shares

On January 1, 2020, the Company issued an aggregate of 2,156,250 shares of common stock (the “Founder Shares”) to the Sponsor for an aggregate purchase price of $25,000. On September 30, 2020, LifeSci Holdings LLC transferred 215,625 Founder Shares to Chardan Healthcare Investments LLC, an investor in the Sponsor. The Founder Shares included an aggregate of up to 153,990 shares of common stock that remained subject to forfeiture by the Sponsor, following the underwriters’ election to partially exercise their over-allotment option so that the number of Founder Shares would collectively represent 20% of the Company’s issued and outstanding shares upon the completion of the Initial Public Offering. On January 8, 2021, the underwriters’ election to exercise their remaining over-allotment option expired unexercised, resulting in 615,959 shares no longer subject to forfeiture and the forfeiture of 153,990 shares. Accordingly, as of January 8, 2021, there are 2,002,260 Founder Shares issued and outstanding (Note 9).

The Sponsor and Chardan Healthcare Investments LLC have agreed that, subject to certain limited exceptions, 50% of the Founder Shares will not be transferred, assigned, sold or released from escrow until the earlier of (i) six months after the date of the consummation of a Business Combination or (ii) the date on which the closing price of the Company’s shares of common stock equals or exceeds $12.50 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations) for any 20 trading days within any 30‑trading day period commencing after a Business Combination and the remaining 50% of the Founder Shares will not be transferred, assigned, sold or released from escrow until six months after the date of the consummation of a Business Combination, or earlier, in either case, if, subsequent to a Business Combination, the Company consummates a subsequent liquidation, merger, stock exchange or other similar transaction which results in all of the stockholders having the right to exchange their shares of common stock for cash, securities or other property.

Administrative Support Agreement

The Company entered into an agreement, commencing on November 20, 2020 through the earlier of the Company’s consummation of a Business Combination and its liquidation, to pay an affiliate of the Sponsor a total of $10,000 per month for office space, utilities and secretarial support. For each of the three and six months ended December 31, 2020, the Company incurred $10,000 in fees for these services, of which such amount is included in accrued expenses in the accompanying unaudited condensed balance sheets.

Promissory Note — Related Party

On June 19, 2020, the Company issued an unsecured promissory note to the Sponsor (the “Promissory Note”), pursuant to which the Company could borrow up to an aggregate principal amount of $175,000. The Promissory Note was non-interest bearing and payable within 15 days of the Sponsor providing the Company with written notice of demand. The outstanding balance under the Promissory Note of $175,000 was repaid at the closing of the Initial Public Offering on November 24, 2020.

Related Party Loans

In order to finance transaction costs in connection with a Business Combination, the Sponsor, an affiliate of the Sponsor, or the Company’s officers and directors may, but are not obligated to, loan the Company funds from time to time or at any time, as may be required (“Working Capital Loans”). Each Working Capital Loan would be evidenced by a promissory note. The Working Capital Loans would be paid upon consummation of a Business Combination, without interest or, at the lender’s discretion, up to $500,000 of such Working Capital Loans may be converted into warrants of the post Business Combination entity at a price of $0.90 per warrant. In the event that a Business Combination does not close, the Company may use a portion of the proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The warrants would be identical to the Private Warrants. As of December 31, 2020 and June 30, 2020, the Company had no outstanding borrowings under the Working Capital Loans.

XML 24 R13.htm IDEA: XBRL DOCUMENT v3.20.4
COMMITMENTS
6 Months Ended
Dec. 31, 2020
COMMITMENTS  
COMMITMENTS

NOTE 6. COMMITMENTS

Risks and Uncertainties

Management continues to evaluate the impact of the COVID‑19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position and/or search for a target company, the specific impact is not readily determinable as of the date of the financial statement. The financial statement does not include any adjustments that might result from the outcome of this uncertainty.

Registration and Stockholder Rights

Pursuant to a registration rights agreement entered into on November 20, 2020, the holders of the Founder Shares and the Private Warrants and any shares that may be issued upon conversion of Working Capital Loans (and all underlying securities) will be entitled to registration and stockholder rights. The holders of a majority of these securities are entitled to make up to two demands that the Company register such securities. The holders of the majority of the Founders Warrants can elect to exercise these registration rights at any time commencing three months prior to the date on which these shares of common stock are to be released from escrow. The holders of a majority of the Private Warrants can elect to exercise these registration rights at any time after the Company consummates a Business Combination. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the consummation of a Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. The Sponsor and its related persons may not, with respect to the Private Warrants purchased by it, (i) have more than one demand registration right at the Company’s expense, (ii) exercise their demand registration rights more than five (5) years from the effective date of the registration statement of the Initial Public Offering, and (iii) exercise their “piggy-back” registration rights more than seven (7) years from the effective date of the Initial Public Offering, as long as the Sponsor or any of its related persons are beneficial owners of Private Warrants.

Underwriting Agreement

The Company granted the underwriters a 45‑day option from the date of the Initial Public Offering to purchase up to 1,125,000 additional Public Shares to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. As a result of the underwriter’s election to partially exercise the over-allotment option to purchase an additional 509,041 Public Shares, a total of 615,959 Public Shares remained available for purchase at a price of $10.00 per Public Share. On January 8, 2021, the underwriters’ election to exercise their remaining over-allotment option expired unexercised (Note 9).

The underwriters were paid cash underwriting discount of $0.20 per Public Share, or $1,601,808 in the aggregate.

Business Combination Marketing Agreement

The Company has engaged LifeSci Capital LLC and Ladenburg Thalmann & Co. Inc. (“Ladenburg Thalmann “) as advisors in connection with a Business Combination to assist the Company in holding meetings with its stockholders to discuss the potential Business Combination and the target business’ attributes, introduce the Company to potential investors that are interested in purchasing the Company’s securities in connection with a Business Combination, assist the Company in obtaining stockholder approval for the Business Combination and assist the Company with its press releases and public filings in connection with the Business Combination. The Company will pay LifeSci Capital LLC and Ladenburg Thalmann a cash fee for such services upon the consummation of a Business Combination in an amount equal to 3.5% of the gross proceeds of the Initial Public Offering, or $2,803,164, (exclusive of any applicable finders’ fees which might become payable) with 75% of such fee payable to LifeSci Capital LLC and 25% to Ladenburg Thalmann; provided that up to 33% of the fee may be allocated in the Company’s sole discretion to other third parties who are investment banks or financial advisory firms not participating in Initial Public Offering that assist the Company in identifying and consummating a Business Combination.

XML 25 R14.htm IDEA: XBRL DOCUMENT v3.20.4
STOCKHOLDERS' EQUITY
6 Months Ended
Dec. 31, 2020
STOCKHOLDERS' EQUITY  
STOCKHOLDERS' EQUITY

NOTE 7. STOCKHOLDERS’ EQUITY

Preferred Stock — The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. At December 31, 2020, there were no shares of preferred stock issued or outstanding.

Common Stock — The Company is authorized to issue 30,000,000 shares of common stock with a par value of $0.0001 per share. Holders of the Company’s common stock are entitled to one vote for each share. At December 31, 2020, there were 2,564,582 shares of common stock issued and outstanding, excluding 7,600,709 shares of common stock subject to possible redemption.

Warrants —The Private Warrants will become exercisable at any time commencing on the later of (1) one year after the closing of the Initial Public Offering or (2) the consummation of a Business Combination; provided that the Company has an effective and current registration statement covering the shares of common stock issuable upon the exercise of the Public Warrants and a current prospectus relating to such shares of common stock.

The Private Warrants purchased by the Sponsor will be exercisable on a cashless basis and not be exercisable more than five years from the commencement of sales of the Initial Public Offering, in accordance with FINRA Rule 5110(g)(8)(A), as long as the Sponsor or any of its related persons beneficially own these Private Warrants.

XML 26 R15.htm IDEA: XBRL DOCUMENT v3.20.4
FAIR VALUE MEASUREMENTS
6 Months Ended
Dec. 31, 2020
FAIR VALUE MEASUREMENTS  
FAIR VALUE MEASUREMENTS

NOTE 8. FAIR VALUE MEASUREMENTS

The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:

Level 1:Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.

Level 2:Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.

Level 3:Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.

At December 31, 2020, assets held in the Trust Account were comprised of $80,095,253 in money market funds which are invested in U.S. Treasury Securities. During the six months ended December 31, 2020, the Company did not withdraw any interest income from the Trust Account.

The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at December 31, 2020 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:

 

 

 

 

 

 

 

 

 

 

 

December 31, 

Description

  

Level

  

2020

Assets:

 

 

 

 

 

Marketable securities held in Trust Account –Money Market Fund

    

 1

    

$

80,095,253

 

XML 27 R16.htm IDEA: XBRL DOCUMENT v3.20.4
SUBSEQUENT EVENTS
6 Months Ended
Dec. 31, 2020
SUBSEQUENT EVENTS  
SUBSEQUENT EVENTS

NOTE 9. SUBSEQUENT EVENTS

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the unaudited condensed financial statements were issued. Based upon this review, other than as described below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements.

On January 8, 2021, the underwriters’ election to exercise their remaining over-allotment option expired unexercised, resulting in the forfeiture of 153,990 Founder Shares. Accordingly, as of January 8, 2021, there are 2,002,260 Founder Shares issued and outstanding.

XML 28 R17.htm IDEA: XBRL DOCUMENT v3.20.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
6 Months Ended
Dec. 31, 2020
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  
Basis of Presentation

Basis of Presentation

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10‑Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s prospectus for its Initial Public Offering as filed with the SEC on November 23, 2020, as well as the Company’s Current Reports on Form 8‑K, as filed with the SEC on November 25, 2020, and December 1, 2020. The interim results for the three and six months ended December 31, 2020 are not necessarily indicative of the results to be expected for the year ending June 30, 2021 or for any future interim periods.

Emerging Growth Company

Emerging Growth Company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

Use of Estimates

The preparation of the unaudited condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

Cash and Cash Equivalents

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of December 31, 2020 and June 30, 2020.

Common Stock Subject to Possible Redemption

Common Stock Subject to Possible Redemption

The Company accounts for its common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at December 31, 2020, common stock subject to possible redemption are presented as temporary equity, outside of the stockholders’ equity section of the Company’s  unaudited condensed balance sheet.

Offering Costs

Offering Costs

Offering costs consist of legal, accounting, underwriting fees and other costs incurred through the balance sheet date that are directly related to the Initial Public Offering. Offering costs amounting to $1,858,498 were charged to stockholders’ equity upon the completion of the Initial Public Offering.

Income Taxes

Income Taxes

The Company complies with the accounting and reporting requirements of ASC Topic 740 “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. As of December 31, 2020, the Company had a deferred tax asset of approximately $17,000, which had a full valuation allowance recorded against it of approximately $17,000.

The Company’s currently taxable income primarily consists of interest income on the Trust Account. The Company’s general and administrative costs are generally considered start-up costs and are not currently deductible. During the three and six months ended December 31, 2020 the Company recorded no income tax expense. The Company’s effective tax rate for the three and six months ended December 31, 2020 was zero, which differs from the expected income tax rate due to the start-up costs which are not currently deductible.

ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2020 and June 30, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

The Company may be subject to potential examination by federal, state and city taxing authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal, state and city tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. The Company is subject to income tax examinations by major taxing authorities since inception.

Net Loss Per Common Share

Net Loss Per Common Share

Net loss per common share is computed by dividing net loss by the weighted average number of common shares outstanding for the period. The Company has not considered the effect of warrants sold in connection with the private placement to purchase 3,146,454 shares of common stock in the calculation of diluted loss per common share, since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive under the treasury stock method.

The Company’s  unaudited condensed statements of operations includes a presentation of loss per share for common shares subject to possible redemption in a manner similar to the two-class method of loss per share. Net income per common share, basic and diluted, for redeemable common stock is calculated by dividing the interest income earned on the Trust Account, less applicable franchise and income taxes, by the weighted average number of redeemable common stock outstanding for the period. Net loss per common share, basic and diluted, for non-redeemable common stock is calculated by dividing the net loss, less income attributable to redeemable common stock, by the weighted average number of non-redeemable common stock outstanding for the period. Weighted average shares were reduced for the effect of an aggregate of 281,250 shares of common stock that were subject to forfeiture if the over-allotment option was not exercised by the underwriters. Non-redeemable common stock includes the Founder Shares as these shares do not have any redemption features and do not participate in the income earned on the Trust Account.

The following table reflects the calculation of basic and diluted net loss per common share (in dollars, except per share amounts):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the Period 

 

 

 

 

 

 

 

 

from

 

 

 

 

 

 

 

 

December 18,

 

 

 

 

 

 

 

 

2019

 

 

Three Months 

 

Six Months 

 

(inception) 

 

 

Ended

 

Ended

 

Through

 

 

December 31, 

 

December 31, 

 

December 31, 

 

    

2020

    

2020

    

2019

Redeemable Common Stock

 

 

  

 

 

  

 

 

  

Numerator: Earnings allocable to Redeemable Common Stock

 

 

  

 

 

  

 

 

  

Interest Income

 

$

4,841

 

$

4,841

 

$

 —

Income and Franchise Tax

 

 

(4,841)

 

 

(4,841)

 

 

 —

Net Earnings

 

$

 —

 

$

 —

 

$

 —

Denominator: Weighted Average Redeemable Common Stock

 

 

  

 

 

  

 

 

  

Redeemable Common Stock, Basic and Diluted

 

 

8,009,041

 

 

8,009,041

 

 

 —

Earnings/Basic and Diluted Redeemable Common Stock

 

$

 —

 

$

 —

 

$

 —

 

 

 

 

 

 

 

 

 

 

Non-Redeemable Common Stock

 

 

  

 

 

  

 

 

  

Numerator: Net Loss minus Redeemable Net Earnings

 

 

  

 

 

  

 

 

  

Net Loss

 

$

(80,543)

 

$

(80,623)

 

$

(1,000)

Redeemable Net Earnings

 

 

 —

 

 

 —

 

 

 —

Non-Redeemable Net Loss

 

$

(80,543)

 

$

(80,623)

 

$

(1,000)

Denominator: Weighted Average Non-Redeemable Common Stock

 

 

  

 

 

  

 

 

  

Non-Redeemable Common Stock, Basic and Diluted

 

 

1,875,000

 

 

1,875,000

 

 

 —

Loss/Basic and Diluted Non-Redeemable Common Stock

 

$

(0.04)

 

$

(0.04)

 

$

0.00

 

Note: As of December 31, 2020, basic and diluted shares are the same as there are no non-redeemable securities that are dilutive to the Company’s stockholders.

Concentration of Credit Risk

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.

Fair Value of Financial Instruments

Fair Value of Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying unaudited condensed balance sheets, primarily due to their short-term nature.

Recent Accounting Standards

Recent Accounting Pronouncements

Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s  unaudited condensed financial statements.

XML 29 R18.htm IDEA: XBRL DOCUMENT v3.20.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
6 Months Ended
Dec. 31, 2020
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  
Summary of the calculation of basic and diluted net loss per common share

The following table reflects the calculation of basic and diluted net loss per common share (in dollars, except per share amounts):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the Period 

 

 

 

 

 

 

 

 

from

 

 

 

 

 

 

 

 

December 18,

 

 

 

 

 

 

 

 

2019

 

 

Three Months 

 

Six Months 

 

(inception) 

 

 

Ended

 

Ended

 

Through

 

 

December 31, 

 

December 31, 

 

December 31, 

 

    

2020

    

2020

    

2019

Redeemable Common Stock

 

 

  

 

 

  

 

 

  

Numerator: Earnings allocable to Redeemable Common Stock

 

 

  

 

 

  

 

 

  

Interest Income

 

$

4,841

 

$

4,841

 

$

 —

Income and Franchise Tax

 

 

(4,841)

 

 

(4,841)

 

 

 —

Net Earnings

 

$

 —

 

$

 —

 

$

 —

Denominator: Weighted Average Redeemable Common Stock

 

 

  

 

 

  

 

 

  

Redeemable Common Stock, Basic and Diluted

 

 

8,009,041

 

 

8,009,041

 

 

 —

Earnings/Basic and Diluted Redeemable Common Stock

 

$

 —

 

$

 —

 

$

 —

 

 

 

 

 

 

 

 

 

 

Non-Redeemable Common Stock

 

 

  

 

 

  

 

 

  

Numerator: Net Loss minus Redeemable Net Earnings

 

 

  

 

 

  

 

 

  

Net Loss

 

$

(80,543)

 

$

(80,623)

 

$

(1,000)

Redeemable Net Earnings

 

 

 —

 

 

 —

 

 

 —

Non-Redeemable Net Loss

 

$

(80,543)

 

$

(80,623)

 

$

(1,000)

Denominator: Weighted Average Non-Redeemable Common Stock

 

 

  

 

 

  

 

 

  

Non-Redeemable Common Stock, Basic and Diluted

 

 

1,875,000

 

 

1,875,000

 

 

 —

Loss/Basic and Diluted Non-Redeemable Common Stock

 

$

(0.04)

 

$

(0.04)

 

$

0.00

 

XML 30 R19.htm IDEA: XBRL DOCUMENT v3.20.4
FAIR VALUE MEASUREMENTS (Tables)
6 Months Ended
Dec. 31, 2020
FAIR VALUE MEASUREMENTS  
Summary of assets that are measured at fair value on a recurring basis

 

 

 

 

 

 

 

 

 

 

December 31, 

Description

  

Level

  

2020

Assets:

 

 

 

 

 

Marketable securities held in Trust Account –Money Market Fund

    

 1

    

$

80,095,253

 

XML 31 R20.htm IDEA: XBRL DOCUMENT v3.20.4
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS - Additional Information (Details) - USD ($)
3 Months Ended 6 Months Ended
Nov. 24, 2020
Sep. 30, 2020
Jan. 01, 2020
Dec. 31, 2019
Dec. 31, 2020
Dec. 31, 2020
Jun. 30, 2020
Subsidiary, Sale of Stock [Line Items]              
Proceeds from sale of Private Warrants       $ 0   $ 2,831,809  
Sale of Stock, Transaction Costs $ 1,858,498            
Cash underwriting fees 1,601,808            
Other offering costs 256,690            
Deferred underwriting fees         $ 1,601,808 1,601,808  
Investment of Cash into Trust Account       0   $ 80,090,412  
Transaction costs $ 1,858,498            
Threshold minimum aggregate fair market value as a percentage of the assets held in the Trust Account           80.00%  
Threshold percentage of outstanding voting securities of the target to be acquired by post-transaction company to complete business combination           50.00%  
Working capital subject to annual limit         250,000 $ 250,000  
Minimum net tangible assets upon consummation of the Business Combination         5,000,001 $ 5,000,001  
Threshold percentage of Public Shares subject to redemption without the Company's prior written consent           20.00%  
Obligation to redeem Public Shares if entity does not complete a Business Combination (as a percent)           100.00%  
Threshold business days for redemption of public shares           5 days  
Cash operating bank account         783,713 $ 783,713 $ 25,000
Aggregate purchase price         $ 78,231,912    
Loan from the Sponsor       $ 0   $ 175,000  
Sponsor | Founder Shares              
Subsidiary, Sale of Stock [Line Items]              
Aggregate purchase price   $ 215,625 $ 25,000        
Initial Public Offering              
Subsidiary, Sale of Stock [Line Items]              
Number of units issued 8,009,041            
Share price per share $ 10.00            
Gross proceeds from sale of units $ 80,090,410            
Over-allotment              
Subsidiary, Sale of Stock [Line Items]              
Number of units issued 509,041         509,041  
Private Placement              
Subsidiary, Sale of Stock [Line Items]              
Number of warrants issued 3,146,454            
Exercise price of warrants $ 0.90            
Proceeds from sale of Private Warrants $ 2,831,809            
XML 32 R21.htm IDEA: XBRL DOCUMENT v3.20.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Class A Common Stock Subject to Possible Redemption (Details) - USD ($)
6 Months Ended
Nov. 24, 2020
Dec. 31, 2020
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES    
Temporary Equity, Shares Outstanding   7,600,709
Transaction costs $ 1,858,498  
Deferred tax asset   $ 17,000
Valuation allowance on deferred tax asset   17,000
Income tax expense   $ 0
Effective tax rate (as a percent)   0.00%
Unrecognized tax benefits   $ 0
Unrecognized tax benefits accrued for interest and penalties   $ 0
XML 33 R22.htm IDEA: XBRL DOCUMENT v3.20.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Net Income (Loss) Per Common Share (Details) - USD ($)
3 Months Ended 6 Months Ended
Dec. 31, 2019
Dec. 31, 2019
Dec. 31, 2020
Sep. 30, 2020
Dec. 31, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Common stock that were subject to forfeiture         281,250
Redeemable Common Stock          
Interest Income $ 0   $ 4,841   $ 4,841
Non-Redeemable Common Stock          
Net loss $ (1,000) $ (1,000) (80,543) $ (80) (80,623)
Redeemable common stock          
Redeemable Common Stock          
Interest Income     4,841   4,841
Income and Franchise Tax     $ (4,841)   $ (4,841)
Non-Redeemable Common Stock          
Weighted average shares outstanding of common stock, Basic and Diluted     8,009,041   8,009,041
Basic and diluted net loss per common share $ 0.00   $ 0.00   $ 0.00
Non-redeemable common stock          
Non-Redeemable Common Stock          
Net loss $ (1,000)   $ (80,543)   $ (80,623)
Non-Redeemable Net Loss $ (1,000)   $ (80,543)   $ (80,623)
Weighted average shares outstanding of common stock, Basic and Diluted     1,875,000   1,875,000
Basic and diluted net loss per common share $ 0.00   $ (0.04)   $ (0.04)
Redeemable warrants          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Shares excluded since their inclusion would be anti-dilutive         3,146,454
XML 34 R23.htm IDEA: XBRL DOCUMENT v3.20.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)
6 Months Ended
Dec. 31, 2020
USD ($)
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  
Federal Depository Insurance Coverage $ 250,000
XML 35 R24.htm IDEA: XBRL DOCUMENT v3.20.4
PUBLIC OFFERING (Details) - $ / shares
6 Months Ended
Nov. 24, 2020
Dec. 31, 2020
Subsidiary, Sale of Stock [Line Items]    
Number of shares issuable per warrant 1  
Initial Public Offering    
Subsidiary, Sale of Stock [Line Items]    
Number of units issued 8,009,041  
Price per share $ 10.00  
Over-allotment    
Subsidiary, Sale of Stock [Line Items]    
Number of units issued 509,041 509,041
XML 36 R25.htm IDEA: XBRL DOCUMENT v3.20.4
PRIVATE PLACEMENT (Details) - USD ($)
6 Months Ended
Nov. 24, 2020
Dec. 31, 2019
Dec. 31, 2020
Subsidiary, Sale of Stock [Line Items]      
Aggregate purchase price   $ 0 $ 2,831,809
Number of shares per warrant 1    
Private Placement      
Subsidiary, Sale of Stock [Line Items]      
Number of warrants issued 3,146,454    
Price of warrants $ 0.90    
Aggregate purchase price $ 2,831,809    
Exercise price of warrant $ 11.50    
XML 37 R26.htm IDEA: XBRL DOCUMENT v3.20.4
RELATED PARTY TRANSACTIONS - Founder Shares (Details)
3 Months Ended
Jan. 08, 2021
shares
Sep. 30, 2020
USD ($)
Jan. 01, 2020
USD ($)
item
$ / shares
shares
Dec. 31, 2020
USD ($)
shares
Jun. 30, 2020
shares
Related Party Transaction [Line Items]          
Sale of Public Shares (in shares)       8,009,041  
Aggregate purchase price | $       $ 78,231,912  
Common stock, shares issued       2,564,582 2,156,250
Common stock, shares outstanding       2,564,582 2,156,250
Founder Shares          
Related Party Transaction [Line Items]          
Percentage of issued and outstanding shares after the Initial Public Offering collectively held by initial stockholders     20.00%    
Founder Shares | First Fifty Percent Of Shares          
Related Party Transaction [Line Items]          
Threshold period for not to transfer, assign or sell any of their shares or warrants after the completion of the initial business combination     6 months    
Percentage of shares or warrants agreed not be transferred, assigned, sold or released from escrow     50.00%    
Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share) | $ / shares     $ 12.50    
Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination | item     20    
Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination | item     30    
Founder Shares | Remaining Fifty Percent Of Shares          
Related Party Transaction [Line Items]          
Percentage of shares or warrants agreed not be transferred, assigned, sold or released from escrow     50.00%    
Founder Shares | Subsequent event          
Related Party Transaction [Line Items]          
Number of shares forfeited 153,990        
Common stock, shares issued 2,002,260        
Common stock, shares outstanding 2,002,260        
Founder Shares | Over-allotment | Subsequent event          
Related Party Transaction [Line Items]          
Number of shares forfeited 153,990        
Common stock, shares issued 2,002,260        
Common stock, shares outstanding 2,002,260        
Sponsor | Founder Shares          
Related Party Transaction [Line Items]          
Sale of Public Shares (in shares)     2,156,250    
Aggregate purchase price | $   $ 215,625 $ 25,000    
Maximum shares subject to forfeiture (in shares)     153,990    
Sponsor | Founder Shares | Subsequent event          
Related Party Transaction [Line Items]          
Number of shares subject to forfeiture (in shares) 615,959        
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.20.4
RELATED PARTY TRANSACTIONS - Additional information (Details) - USD ($)
6 Months Ended
Nov. 20, 2020
Jun. 19, 2020
Dec. 31, 2019
Dec. 31, 2020
Jun. 30, 2020
Related Party Transaction [Line Items]          
Repayment of promissory note - related party     $ 0 $ 175,000  
Administrative Support Agreement          
Related Party Transaction [Line Items]          
Expenses per month $ 10,000        
Expenses incurred $ 10,000        
Promissory Note with Related Party          
Related Party Transaction [Line Items]          
Period To Repay Debt After Receiving Written Notice Of Demand   15 days      
Repayment of promissory note - related party   $ 175,000      
Related Party Loans          
Related Party Transaction [Line Items]          
Outstanding borrowings       0 $ 0
Maximum loans convertible into warrants       $ 500,000  
Price of warrants (in dollars per share)       $ 0.90  
XML 39 R28.htm IDEA: XBRL DOCUMENT v3.20.4
COMMITMENTS - Registration and Stockholder Rights (Details)
6 Months Ended
Dec. 31, 2020
item
COMMITMENTS  
Maximum demands that entity register on securities 2
Threshold period to exercise registration rights 3 months
Maximum demand registration right at entity's expense 1
Threshold period to exercise registration rights from the effective date of registration statement of Initial Public Offering 5 years
Threshold period to exercise "piggy-back" registration rights from the effective date of registration statement of Initial Public Offering 7 years
XML 40 R29.htm IDEA: XBRL DOCUMENT v3.20.4
COMMITMENTS - Underwriting Agreement (Details) - USD ($)
6 Months Ended
Nov. 24, 2020
Dec. 31, 2020
Jun. 30, 2020
Commitments And Contingencies [Line Items]      
Common Stock, Shares Authorized   30,000,000 30,000,000
Deferred fee per unit   $ 0.20  
Deferred underwriting fee payable   $ 1,601,808  
Over-allotment      
Commitments And Contingencies [Line Items]      
Common Stock, Shares Authorized   1,125,000  
Number of units issued 509,041 509,041  
Unit price   $ 10.00  
Number of units available   615,959  
XML 41 R30.htm IDEA: XBRL DOCUMENT v3.20.4
COMMITMENTS - Business combination marketing agreement (Details)
6 Months Ended
Dec. 31, 2020
USD ($)
LifeSci Capital LLC  
Commitments And Contingencies [Line Items]  
Cash fee for services as percentage of gross proceeds of IPO 3.50%
Cash fee for services on gross proceeds of IPO $ 2,803,164
Percentage of fees payable to service provider 75.00%
Ladenburg Thalmann  
Commitments And Contingencies [Line Items]  
Percentage of fees payable to service provider 25.00%
Percentage of fees that can be allocated to third party service provider 33.00%
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.20.4
STOCKHOLDERS' EQUITY - Preferred Stock Shares (Details) - $ / shares
Dec. 31, 2020
Jun. 30, 2020
STOCKHOLDERS' EQUITY    
Preferred shares, shares authorized 1,000,000 1,000,000
Preferred shares, par value $ 0.0001 $ 0.0001
Preferred shares, shares issued 0 0
Preferred shares, shares outstanding 0 0
XML 43 R32.htm IDEA: XBRL DOCUMENT v3.20.4
STOCKHOLDERS' EQUITY - Common Stock Shares (Details)
Dec. 31, 2020
Vote
$ / shares
shares
Jun. 30, 2020
$ / shares
shares
Class of Stock [Line Items]    
Common shares, shares authorized (in shares) 30,000,000 30,000,000
Common shares, par value (in dollars per share) | $ / shares $ 0.0001 $ 0.0001
Common shares, votes per share | Vote 1  
Common shares, shares issued (in shares) 2,564,582 2,156,250
Common shares, shares outstanding (in shares) 2,564,582 2,156,250
Shares subject to possible redemption 7,600,709  
Over-allotment    
Class of Stock [Line Items]    
Common shares, shares authorized (in shares) 1,125,000  
XML 44 R33.htm IDEA: XBRL DOCUMENT v3.20.4
STOCKHOLDERS' EQUITY - Warrants (Details) - Redeemable warrants
6 Months Ended
Dec. 31, 2020
Class of Warrant or Right [Line Items]  
Public Warrants exercisable term from the closing of the initial public offering 1 year
Public Warrants expiration term 5 years
XML 45 R34.htm IDEA: XBRL DOCUMENT v3.20.4
FAIR VALUE MEASUREMENTS - Gross holding gains and fair value of held-to-maturity securities (Details)
Dec. 31, 2020
USD ($)
Debt Securities, Held-to-maturity, Fair Value to Amortized Cost [Abstract]  
Assets held in the Trust Account $ 80,095,253
Level 1 | Recurring  
Debt Securities, Held-to-maturity, Fair Value to Amortized Cost [Abstract]  
Marketable securities held in Trust Account -Money Market Fund $ 80,095,253
XML 46 R35.htm IDEA: XBRL DOCUMENT v3.20.4
SUBSEQUENT EVENTS (Details) - shares
Jan. 08, 2021
Dec. 31, 2020
Jun. 30, 2020
Subsequent Event [Line Items]      
Common stock, shares issued   2,564,582 2,156,250
Common stock, shares outstanding   2,564,582 2,156,250
Subsequent event | Founder Shares      
Subsequent Event [Line Items]      
Number of shares forfeited 153,990    
Common stock, shares issued 2,002,260    
Common stock, shares outstanding 2,002,260    
Over-allotment | Subsequent event | Founder Shares      
Subsequent Event [Line Items]      
Number of shares forfeited 153,990    
Common stock, shares issued 2,002,260    
Common stock, shares outstanding 2,002,260    
EXCEL 47 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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

MSZXAT/7 $S$-8&5J(V1MC)E[$9/QE'? /!*@/<8X&P ^"7 -T8+9<;6"$L\ MZ'&V0EQ'*S8],+4Q:.6&I/HQ3B17JT3AY&!R>3;\?')V.CJ^F+Q'QU^OQI?? MT3X:LB1119Y(-KM!DQAS$&AG!!(3*G9[ME29-=Z>E5F.BBS>ABPCF+60[^XA MS_&<:R;A';*1,+3%?P/E<#OEISQ5E$Y!N9W.5C6I"N-5A?$,O[^!?TBQ$(C- MRQK\.%7K:"PA$3^WL/L5NV_8VYO8B_H6:O?**\*YC!DG?R%".^1NM;'=)MW=-3V=T'$Z MSD&SGH-*S\%6/6=+X/N84B95UY1;SAS7N3_KG3/IKXPOF"Y(*1&&ND$ZKHRAXT<"+B629Z8%3)E5'-<-8??0 UP%J M?<[4&UY.=%NM/J,&_P%02P,$% @ R8!"4HT=V[51 @ 5P4 !D !X M;"]W;W)K&ULE51M;]HP$/XKIWS9)FU-"*6;*D J MT*G56I5!NVJ:]L$D%V+5+YE]-/3?SW9"RB2*M"^Q[WSWW/-5FR-2Z2':FZ<%7H M+-<*#!:CZ*)W/AGX^!#P@V-M]_;@E:RT?O+&=3Z*$D\(!6;D$9A;GG&*0G@@ M1^-/BQEU)7WB_GZ'_C5H=UI6S.)4BT>>4SF*OD208\$V@A:ZOL)63R"8:6'# M%^HV-HD@VUC2LDUV#"17S7\W_79U=S.[7"S?P>7WA^O[G_ )'IDQ3)&% M]S,DQH7]X)P+S-%=B95 J-OS84R.A(>*L[;@I"F8OE'P#&ZUHM+"IE.P20]"CC#[ 3ZO8^0)FER!*_?=:0?\/IOX$T%LQ9TL>L!: /AKL*O M&Q<*UX32_CY2Z+0K=!H*G;Y1:+Y9"9Z]MAJW:#)N0W\)C83": E4(F1"6Z[6 MGI0WN>+$F8"J =!%@<8='_H7QQGTX 69.2)ET$D9_*>4BAL6QLXK.<3L.. @ M,+.'J,5[EUVB68>1MI#IC:+FWG?>[M6X:(;E-;QY&ULQ511 M;]HP$/XKIV@/G52:$ KKJH"4%E@KE:F"TCU,>S#)0:PZ,;,O4*;]^-E.B%A5 MT-[VDMS9=Y^_[\Z^:"O5B\X0"5YS4>B^EQ&MKWU?)QGF3%_(-19F9RE5SLBX M:N7KM4*6NJ1<^&$0]/R<\<(;1&[M40TB69+@!3XJT&6>,[6[02&W?:_M[1>F M?)617? 'T9JM<(8T7S\JX_D-2LIS+#27!2A<]KVX?7W3L_$NX)GC5A_88)4L MI'RQSGW:]P)+" 4F9!&8^6WP%H6P0(;&SQK3:XZTB8?V'GWLM!LM"Z;Q5HIO M/*6L[UUYD.*2E8*F,V"!2<@O*1ALT:SBI+MN0XX5MRHR4V>4FCP;C^'X* MS_'#? 2343R;3T>3T=>G&;3@BY):0R9%RHL5K$Q_-; BA27C"C9,E AR"1F* MM$6R9>I3*DX[T)A8@Z.&LR$2XT)_C'PR5.V!?E+3NJEHA4=H#3&Y@$[[',(@ M#.:S(9Q]>(/B&Z&-VK!1&SK8SE'8!<&L87@.=V_HG\/8RGMV\DA"G$M%_!>F M<"LUP?=XH4F9F_3C!)E.0Z;CR%P>(1-KC:1=!8$70!G"DS(=ASA)9%G0>U6K M$'L.T;ZWS> J"#YWPVXG\C?O<+ELN%R>Y/* &Q30AM\PM=51IN4G%'8;U.[_ M+W>O(=,[*7'"U(NYCPN!AW=T7_V_*@^MB2QP!U4*C,LB?:\9O7]MAG_P/NVH M,[@K^YP$+DUJ&ULM59=;]HP%/TK5IXVJ25Q0OBH &D!JG7:NJZLW<.T!T,N M8#6.J>U )^W'SW9"H&K(J$9?$CNYY_C0ZC=S+AA1>BH6KEP)(+$%L<3U/:_E,D)39]"SSV[$H,<#OACAI@'8B'L*&[DW1B:5*>)S,E$H8\^4%CM>P['0?%,"=9HF[YYB,4"86&;\83::]H MD\>&>L59)A5G!5C/&4WS.WDJC-@#Z$2K 7X!\(\%! 4@.!;0+ #6:C=/Q?HP M(HH,>H)OD##1FLT,K)D6K=.GJ=GWB1+Z+=4X-9C<19/QM[OQ]795,)CQFD"HW7YOKSLXY 5PJ8 M_%7#'Y3\@>5O'N ?O9P5GB.J)09Q%7>Y62A)3.?]7K@AZUFV/%[ M[GK?I(HX'+;\T"OCGJEMEFJ;KU>K.XI4)(UINJB2W#Q22PE!S62M[; M0+ ;^ ==\BR-0:!)184_6Z-5KM%ZDR)IE_SMVARN,S;5>OE\:[GN^7.@JK)& MHO8+(W$8=+L'?.R4&CHG+-2H\W(W/<_W6P=4=$L5W5,78-1]G13L[=JG5ROF MZQK$.4D2KEA>6/]3:WBO:^,WJ3:\ZWG8/V&]%63'%AS>M49\RMX8X8JF5[O1 MNZZ'3][V(ES1SRK5N'L_<'/<^D+$@J82)3#72*_1UA0B/\'D$\57]I\^Y4J? M$.QPJ4]]($R ?C_G7&TGYIA0GB,'?P%02P,$% @ R8!"4@GT/8$T @ MW0D T !X;"]S='EL97,N>&ULU59=:]LP%/TK0AFCA5''Z9+1U39LA<)@ M*X7F86]%L:]M@3X\6(C1I[N1F80X\>S][\:J:_?(3]./DPFT\?S MZWW\S 7.;BJCL%!D$\[F>+O #2;) M2JH,U) FQ#V41 QR*T?1HK2CEE5@@UI+;HR,DD(*XC3T*SK#T*; V(.]VC_S M'>XV'YWJU)ZI&$PCJ#,]C7X.:_VV="Q"@"!N+-E?_E*O\:L67G_Z79/=1V1?\HL:N M79VZR/E;$+DX29%!]T$?=8V=GC&@R/;F&-_9=P#;)D6KAC)-1>>5-,M /&L= MAEZ3E7EK[?";^1GDI&%Z.01CO+5_0$8;?C7,NK>%Z&9M[>]V>^'")=P^Z)(_ M4$L#!!0 ( ,F 0E*7BKL

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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 49 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 50 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.4 html 60 240 1 false 23 0 false 6 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://www.lifesciacquisition.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00100 - Statement - CONDENSED BALANCE SHEET Sheet http://www.lifesciacquisition.com/role/StatementCondensedBalanceSheet CONDENSED BALANCE SHEET Statements 2 false false R3.htm 00105 - Statement - CONDENSED BALANCE SHEET (Parenthetical) Sheet http://www.lifesciacquisition.com/role/StatementCondensedBalanceSheetParenthetical CONDENSED BALANCE SHEET (Parenthetical) Statements 3 false false R4.htm 00200 - Statement - CONDENSED STATEMENTS OF OPERATIONS Sheet http://www.lifesciacquisition.com/role/StatementCondensedStatementsOfOperations CONDENSED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 00300 - Statement - CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY Sheet http://www.lifesciacquisition.com/role/StatementCondensedStatementOfChangesInStockholdersEquity CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY Statements 5 false false R6.htm 00305 - Statement - CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Parenthetical) Sheet http://www.lifesciacquisition.com/role/StatementCondensedStatementOfChangesInStockholdersEquityParenthetical CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Parenthetical) Statements 6 false false R7.htm 00400 - Statement - CONDENSED STATEMENT OF CASH FLOWS Sheet http://www.lifesciacquisition.com/role/StatementCondensedStatementOfCashFlows CONDENSED STATEMENT OF CASH FLOWS Statements 7 false false R8.htm 10101 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Sheet http://www.lifesciacquisition.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperations DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Notes 8 false false R9.htm 10201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.lifesciacquisition.com/role/DisclosureSummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 9 false false R10.htm 10301 - Disclosure - PUBLIC OFFERING Sheet http://www.lifesciacquisition.com/role/DisclosurePublicOffering PUBLIC OFFERING Notes 10 false false R11.htm 10401 - Disclosure - PRIVATE PLACEMENT Sheet http://www.lifesciacquisition.com/role/DisclosurePrivatePlacement PRIVATE PLACEMENT Notes 11 false false R12.htm 10501 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://www.lifesciacquisition.com/role/DisclosureRelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 12 false false R13.htm 10601 - Disclosure - COMMITMENTS Sheet http://www.lifesciacquisition.com/role/DisclosureCommitments COMMITMENTS Notes 13 false false R14.htm 10701 - Disclosure - STOCKHOLDERS' EQUITY Sheet http://www.lifesciacquisition.com/role/DisclosureStockholdersEquity STOCKHOLDERS' EQUITY Notes 14 false false R15.htm 10801 - Disclosure - FAIR VALUE MEASUREMENTS Sheet http://www.lifesciacquisition.com/role/DisclosureFairValueMeasurements FAIR VALUE MEASUREMENTS Notes 15 false false R16.htm 10901 - Disclosure - SUBSEQUENT EVENTS Sheet http://www.lifesciacquisition.com/role/DisclosureSubsequentEvents SUBSEQUENT EVENTS Notes 16 false false R17.htm 20202 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://www.lifesciacquisition.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 17 false false R18.htm 30203 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://www.lifesciacquisition.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://www.lifesciacquisition.com/role/DisclosureSummaryOfSignificantAccountingPolicies 18 false false R19.htm 30803 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) Sheet http://www.lifesciacquisition.com/role/DisclosureFairValueMeasurementsTables FAIR VALUE MEASUREMENTS (Tables) Tables http://www.lifesciacquisition.com/role/DisclosureFairValueMeasurements 19 false false R20.htm 40101 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS - Additional Information (Details) Sheet http://www.lifesciacquisition.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetails DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS - Additional Information (Details) Details 20 false false R21.htm 40201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Class A Common Stock Subject to Possible Redemption (Details) Sheet http://www.lifesciacquisition.com/role/DisclosureSummaryOfSignificantAccountingPoliciesClassCommonStockSubjectToPossibleRedemptionDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Class A Common Stock Subject to Possible Redemption (Details) Details 21 false false R22.htm 40202 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Net Income (Loss) Per Common Share (Details) Sheet http://www.lifesciacquisition.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetIncomeLossPerCommonShareDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Net Income (Loss) Per Common Share (Details) Details 22 false false R23.htm 40203 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Sheet http://www.lifesciacquisition.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Details http://www.lifesciacquisition.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables 23 false false R24.htm 40301 - Disclosure - PUBLIC OFFERING (Details) Sheet http://www.lifesciacquisition.com/role/DisclosurePublicOfferingDetails PUBLIC OFFERING (Details) Details http://www.lifesciacquisition.com/role/DisclosurePublicOffering 24 false false R25.htm 40401 - Disclosure - PRIVATE PLACEMENT (Details) Sheet http://www.lifesciacquisition.com/role/DisclosurePrivatePlacementDetails PRIVATE PLACEMENT (Details) Details http://www.lifesciacquisition.com/role/DisclosurePrivatePlacement 25 false false R26.htm 40501 - Disclosure - RELATED PARTY TRANSACTIONS - Founder Shares (Details) Sheet http://www.lifesciacquisition.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails RELATED PARTY TRANSACTIONS - Founder Shares (Details) Details 26 false false R27.htm 40502 - Disclosure - RELATED PARTY TRANSACTIONS - Additional information (Details) Sheet http://www.lifesciacquisition.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails RELATED PARTY TRANSACTIONS - Additional information (Details) Details 27 false false R28.htm 40601 - Disclosure - COMMITMENTS - Registration and Stockholder Rights (Details) Sheet http://www.lifesciacquisition.com/role/DisclosureCommitmentsRegistrationAndStockholderRightsDetails COMMITMENTS - Registration and Stockholder Rights (Details) Details 28 false false R29.htm 40602 - Disclosure - COMMITMENTS - Underwriting Agreement (Details) Sheet http://www.lifesciacquisition.com/role/DisclosureCommitmentsUnderwritingAgreementDetails COMMITMENTS - Underwriting Agreement (Details) Details 29 false false R30.htm 40603 - Disclosure - COMMITMENTS - Business combination marketing agreement (Details) Sheet http://www.lifesciacquisition.com/role/DisclosureCommitmentsBusinessCombinationMarketingAgreementDetails COMMITMENTS - Business combination marketing agreement (Details) Details 30 false false R31.htm 40701 - Disclosure - STOCKHOLDERS' EQUITY - Preferred Stock Shares (Details) Sheet http://www.lifesciacquisition.com/role/DisclosureStockholdersEquityPreferredStockSharesDetails STOCKHOLDERS' EQUITY - Preferred Stock Shares (Details) Details 31 false false R32.htm 40702 - Disclosure - STOCKHOLDERS' EQUITY - Common Stock Shares (Details) Sheet http://www.lifesciacquisition.com/role/DisclosureStockholdersEquityCommonStockSharesDetails STOCKHOLDERS' EQUITY - Common Stock Shares (Details) Details 32 false false R33.htm 40703 - Disclosure - STOCKHOLDERS' EQUITY - Warrants (Details) Sheet http://www.lifesciacquisition.com/role/DisclosureStockholdersEquityWarrantsDetails STOCKHOLDERS' EQUITY - Warrants (Details) Details 33 false false R34.htm 40801 - Disclosure - FAIR VALUE MEASUREMENTS - Gross holding gains and fair value of held-to-maturity securities (Details) Sheet http://www.lifesciacquisition.com/role/DisclosureFairValueMeasurementsGrossHoldingGainsAndFairValueOfHeldToMaturitySecuritiesDetails FAIR VALUE MEASUREMENTS - Gross holding gains and fair value of held-to-maturity securities (Details) Details 34 false false R35.htm 40901 - Disclosure - SUBSEQUENT EVENTS (Details) Sheet http://www.lifesciacquisition.com/role/DisclosureSubsequentEventsDetails SUBSEQUENT EVENTS (Details) Details http://www.lifesciacquisition.com/role/DisclosureSubsequentEvents 35 false false All Reports Book All Reports lsaq-20201231.xml lsaq-20201231.xsd lsaq-20201231_cal.xml lsaq-20201231_def.xml lsaq-20201231_lab.xml lsaq-20201231_pre.xml http://fasb.org/srt/2020-01-31 http://fasb.org/us-gaap/2020-01-31 http://xbrl.sec.gov/dei/2020-01-31 true true ZIP 52 0001104659-21-010906-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-21-010906-xbrl.zip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end